Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• 'TIDieR-ing up' the reporting of interventions in stroke research: the importance of knowing what is in the 'black box'.1 passage
• (untitled)1 passage
• 14th International Symposium on Thrombolysis, Thrombectomy and Acute Stroke Therapy: Proceedings and summary of discussions.1 passage
• 20-year trends of characteristics and outcomes of stroke patients with atrial fibrillation.1 passage
• 2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack.1 passage
• 4G versus 3G-enabled telemedicine in prehospital acute stroke care.1 passage
• 7 Tesla MRI in cerebral small vessel disease.1 passage
• A Phase 1 exercise dose escalation study for stroke survivors with impaired walking.1 passage
• A behavior change program to increase outings delivered during therapy to stroke survivors by community rehabilitation teams: The Out-and-About trial.1 passage
• A collaborative sequential meta-analysis of individual patient data from randomized trials of endovascular therapy and tPA vs. tPA alone for acute ischemic stroke: ThRombEctomy And tPA (TREAT) analysis: statistical analysis plan for a sequential meta-analysis performed within the VISTA-Endovascular collaboration.1 passage
• A comparison between the MoCA and the MMSE visuoexecutive sub-tests in detecting abnormalities in TIA/stroke patients.1 passage
• A comparison of location of acute symptomatic vs. 'silent' small vessel lesions.1 passage
• A core outcome set for aphasia treatment research: The ROMA consensus statement.1 passage
• A critical review of Early Supported Discharge for stroke patients: from evidence to implementation into practice.1 passage
• A double-tuned (1) H/(23) Na resonator allows (1) H-guided (23) Na-MRI in ischemic stroke patients in one session.1 passage
• A guideline-based program may improve the outcome of stroke among illiterate patients.1 passage
• A meta-analysis of aspirin and subarachnoid hemorrhage in patients with intracranial aneurysms yields different results to the general population.1 passage
• A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3).1 passage
• A multicenter, randomized trial on neuroprotection with remote ischemic per-conditioning during acute ischemic stroke: the REmote iSchemic Conditioning in acUtE BRAin INfarction study protocol.1 passage
• A national economic and clinical model for ischemic stroke care development in Saudi Arabia: A call for change.1 passage
• A pathological perspective on the natural history of cerebral atherosclerosis.1 passage
• A practical approach to the management of cerebral amyloid angiopathy.1 passage
• A pragmatic, multi-centered, stepped wedge, cluster randomized controlled trial pilot of the clinical and cost effectiveness of a complex Stroke Oral healthCare intervention pLan Evaluation II (SOCLE II) compared with usual oral healthcare in stroke wards.1 passage
• A prospective population-based study of stroke in the Central Region of Iran: The Qom Incidence of Stroke Study.1 passage
• A protocol for precise comparisons of small vessel disease lesions between ex vivo magnetic resonance imaging and histopathology.1 passage
• A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III).1 passage
• A randomized control trial of intensive aphasia therapy after acute stroke: The Very Early Rehabilitation for SpEech (VERSE) study.1 passage
• A randomized controlled trial of very early rehabilitation in speech after stroke.1 passage
• A randomized controlled trial on rehabilitation through caregiver-delivered nurse-organized service programs for disabled stroke patients in rural china (the RECOVER trial): design and rationale.1 passage
• A randomized controlled trial to test efficacy and safety of thrombectomy in stroke with extended lesion and extended time window.1 passage
• A review of epidemiological research on stroke and dementia and exposure to air pollution.1 passage
• A score based on age and DWI volume predicts poor outcome following endovascular treatment for acute ischemic stroke.1 passage
• A score for paroxysmal atrial fibrillation in acute ischemic stroke.1 passage
• A score to predict one-year risk of recurrence after acute ischemic stroke.1 passage
• A stroke recovery trial development framework: Consensus-based core recommendations from the Second Stroke Recovery and Rehabilitation Roundtable.1 passage
• A systematic review and meta-analysis of randomized controlled trials of endovascular thrombectomy compared with best medical treatment for acute ischemic stroke.1 passage
• A telehealth intervention to promote healthy lifestyles after stroke: The Stroke Coach protocol.1 passage
• APOE/TOMM40 genetic loci, white matter hyperintensities, and cerebral microbleeds.1 passage
• ASPECTS-based selection for late endovascular treatment: a retrospective two-site cohort study.1 passage
• ASPREE-NEURO study protocol: A randomized controlled trial to determine the effect of low-dose aspirin on cerebral microbleeds, white matter hyperintensities, cognition, and stroke in the healthy elderly.1 passage
• Absence of susceptibility vessel sign is associated with aspiration-resistant fibrin/platelet-rich thrombi.1 passage
• Absent hyperdense middle cerebral artery sign is associated with poor functional outcome after mechanical thrombectomy.1 passage
• Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes (SOCRATES) trial: rationale and design.1 passage
• Acute basilar artery occlusion: Endovascular Interventions versus Standard Medical Treatment (BEST) Trial-Design and protocol for a randomized, controlled, multicenter study.1 passage
• Acute diffusion-weighted imaging lesion patterns predict progressive small subcortical infarct in the perforator territory of the middle cerebral artery.1 passage
• Acute endovascular treatment delivery to ischemic stroke patients transferred within a telestroke network: a retrospective observational study.1 passage
• Acute ischemic myelopathy treated with intravenous thrombolysis: Four new cases and literature review.1 passage
• Addressing inactivity after stroke: The Collaborative Rehabilitation in Acute Stroke (CREATE) study.1 passage
• Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0.1 passage
• Adverse effects of pre-existing cerebral small vessel disease on cognitive improvement after carotid endarterectomy.1 passage
• Adverse outcome after incident stroke hospitalization for Indigenous and non-Indigenous Australians in the Northern Territory.1 passage
• Age and sex distribution of beat-to-beat blood pressure variability after transient ischemic attack and minor stroke: A population-based study.1 passage
• Age and sex-specific associations of carotid pulsatility with small vessel disease burden in transient ischemic attack and ischemic stroke.1 passage
• Age-dependent clinical outcomes in primary versus oral anticoagulation-related intracerebral hemorrhage.1 passage
• Age-related differences in the rate and diagnosis of 30-day readmission after hospitalization for acute ischemic stroke.1 passage
• Agreed definitions and a shared vision for new standards in stroke recovery research: The Stroke Recovery and Rehabilitation Roundtable taskforce.1 passage
• Air, rail and road: Medical Guidelines for Employees with a History of Cerebrovascular Disease.1 passage
• Air-Mobile Stroke Unit for access to stroke treatment in rural regions.1 passage
• Alteplase for the treatment of acute ischemic stroke in patients with low National Institutes of Health Stroke Scale and not clearly disabling deficits (Potential of rtPA for Ischemic Strokes with Mild Symptoms PRISMS): Rationale and design.1 passage
• Altering the rehabilitation environment to improve stroke survivor activity: A Phase II trial.1 passage
• Ambient temperature and volume of perihematomal edema in acute intracerebral haemorrhage: the INTERACT1 study.1 passage
• Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053).1 passage
• An update of the Italian Stroke Organization-Stroke Prevention Awareness Diffusion Group guidelines on carotid endarterectomy and stenting: A personalized medicine approach.1 passage
• Anaemia on admission is associated with more severe intracerebral haemorrhage and worse outcomes.1 passage
• Analyses of thrombi in acute ischemic stroke: A consensus statement on current knowledge and future directions.1 passage
• Anatomical characteristics of the styloid process in internal carotid artery dissection: Case-control study.1 passage
• Anemia on admission predicts short- and long-term outcomes in patients with acute ischemic stroke.1 passage
• Anesthetic strategy during endovascular therapy: General anesthesia or conscious sedation? (GOLIATH - General or Local Anesthesia in Intra Arterial Therapy) A single-center randomized trial.1 passage
• Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection.1 passage
• Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany-Updated series of 120 cases.1 passage
• Anticoagulation in patients with Embolic Stroke of Unknown Source.1 passage
• Antihypertensive treatment should be commenced in hospital after stroke: Pro.1 passage
• Antiplatelet vs. R-tPA for acute mild ischemic stroke: A prospective, random, and open label multi-center study.1 passage
• Antithrombotic treatment at onset of stroke with atrial fibrillation, functional outcome, and fatality: a systematic review and meta-analysis.1 passage
• Anxiety after stroke: time for an intervention.1 passage
• Aortic stiffness and plasma brain natriuretic peptide predicts mortality in acute ischemic stroke.1 passage
• Apathy after stroke: Diagnosis, mechanisms, consequences, and treatment.1 passage
• Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): Rationale and study design.1 passage
• Apparent diffusion coefficient threshold for delineation of ischemic core.1 passage
• Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry.1 passage
• Application of the World Stroke Organization health system indicators and performance in Australia, Singapore, and the USA.1 passage
• Applying principles from the game theory to acute stroke care: Learning from the prisoner's dilemma, stag-hunt, and other strategies.1 passage
• Approaches to the field recognition of potential thrombectomy candidates.1 passage
• Approval of Stroke and Cardiovascular Disease Control Act in Japan: Comprehensive nationwide approach for prevention, treatment, and patients' support.1 passage
• Are low doses of non-vitamin K antagonists effective in Chinese patients with atrial fibrillation? A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.1 passage
• Aspirin for primary prevention of stroke in individuals without cardiovascular disease-A meta-analysis.1 passage
• Assessing cognition after stroke. Who misses out? A systematic review.1 passage
• Assessment and provision of rehabilitation among patients hospitalized with acute ischemic stroke in China: Findings from the China National Stroke Registry II.1 passage
• Association between atherogenic dyslipidemia and recurrent stroke risk in patients with different subtypes of ischemic stroke.1 passage
• Association between comorbid cancer and outcomes among admissions for acute ischemic stroke receiving systemic thrombolysis.1 passage
• Association between estimated pulse wave velocity and the risk of stroke in middle-aged men.1 passage
• Association between the maximal distance of atrial septal protrusion and cryptogenic stroke.1 passage
• Association of baseline hematoma and edema volumes with one-year outcome and long-term survival after spontaneous intracerebral hemorrhage: A community-based inception cohort study.1 passage
• Asymptomatic carotid stenosis is associated with gray and white matter damage.1 passage
• Atrial cardiopathy and stroke mortality in the general population.1 passage
• Atrial fibrillation trial to evaluate real-world procedures for their utility in helping to lower stroke events: A randomized clinical trial.1 passage
• Australian Clinical Consensus Guideline: The diagnosis and acute management of childhood stroke.1 passage
• Australian clinical consensus guideline for the subacute rehabilitation of childhood stroke.1 passage
• Baseline NIH Stroke Scale is an inferior predictor of functional outcome in the era of acute stroke intervention.1 passage
• Baseline characteristics of the 1149 patients recruited into the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) randomized controlled trial.1 passage
• Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trial.1 passage
• Basilar Artery Occlusion Chinese Endovascular Trial: Protocol for a prospective randomized controlled study.1 passage
• Beauty parlor stroke revisited: An 11-year single-center consecutive series.1 passage
• Benefits of stroke treatment delivered using a mobile stroke unit trial.1 passage
• Benign neoplasm of the heart increases the risk of first ischemic stroke: a population-based cohort study.1 passage
• Berlin prehospital or usual delivery of acute stroke care - Study protocol.1 passage
• Beyond antiplatelets: The role of glycoprotein VI in ischemic stroke.1 passage
• Bilateral versus ipsilesional cortico-subcortical activity patterns in stroke show hemispheric dependence.1 passage
• Biomarkers in adult posthemorrhagic hydrocephalus.1 passage
• Biomarkers of stroke recovery: Consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable.1 passage
• Blood biomarkers associated with neurological deterioration in patients with acute penetrating artery territory infarction: A multicenter prospective observational study.1 passage
• Blood biomarkers for the diagnosis and differentiation of stroke: A systematic review and meta-analysis.1 passage
• Blood pressure burden and outcome in warfarin-related intracerebral hemorrhage.1 passage
• Blood pressure variability and leukoaraiosis in acute ischemic stroke.1 passage
• Blood pressure-lowering therapy post stroke should be commenced before discharge from hospital: Contra.1 passage
• Brain atrophy and endovascular treatment effect in acute ischemic stroke: a secondary analysis of the MR CLEAN trial.1 passage
• Branch atheromatous disease diagnosed as embolic stroke of undetermined source: A sub-analysis of NAVIGATE ESUS.1 passage
• Breaking up sitting time after stroke (BUST-Stroke).1 passage
• Breaking up sitting time after stroke (BUST-stroke).1 passage
• Bridges self-management program for people with stroke in the community: A feasibility randomized controlled trial.1 passage
• Bringing stroke clinical guidelines to life.1 passage
• Burden of large vessel occlusion stroke and the service gap of thrombectomy: A population-based study using a territory-wide public hospital system registry.1 passage
• Burden of stroke in Italy: an economic model highlights savings arising from reduced disability following thrombolysis.1 passage
• Burden of stroke in Puerto Rico.1 passage
• COVID-19 and stroke-A global World Stroke Organization perspective.1 passage
• COVID-19 and stroke-Understanding the relationship and adapting services. A global World Stroke Organisation perspective.1 passage
• COVID-19-related strokes are associated with increased mortality and morbidity: A multicenter comparative study from Bengaluru, South India.1 passage
• CT perfusion core and ASPECT score prediction of outcomes in DEFUSE 3.1 passage
• CT-angiography source images indicate less fatal outcome despite coma of patients in the Basilar Artery International Cooperation Study.1 passage
• Calcifications in the carotid siphon inversely associate with cognitive performance in stroke-free community dwellers living in rural Ecuador (The Atahualpa Project).1 passage
• Canadian Stroke Best Practice Consensus Statement: Acute Stroke Management during pregnancy.1 passage
• Canadian Stroke Best Practice Recommendations for Acute Stroke Management: Prehospital, Emergency Department, and Acute Inpatient Stroke Care, 6th Edition, Update 2018.1 passage
• Canadian Stroke Best Practice Recommendations: Managing transitions of care following Stroke, Guidelines Update 2016.1 passage
• Canadian Stroke Best Practice Recommendations: Rehabilitation, Recovery, and Community Participation following Stroke.1 passage
• Canadian Stroke Best Practice Recommendations: Rehabilitation, Recovery, and Community Participation following Stroke. Part Two: Transitions and Community Participation Following Stroke.1 passage
• Canadian Stroke Best Practice Recommendations: Telestroke Best Practice Guidelines Update 2017.1 passage
• Canadian Stroke Best Practice Recommendations: secondary prevention of stroke guidelines, update 2014.1 passage
• Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy.1 passage
• Canadian stroke best practice recommendations:1 passage
• Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017.1 passage
• Canadian stroke best practice recommendations: Stroke rehabilitation practice guidelines, update 2015.1 passage
• Canadian Stroke Best Practice Recommendations: Hyperacute Stroke Care Guidelines, Update 2015.1 passage
• Canadian Stroke Best Practice Recommendations: Mood, Cognition and Fatigue Following Stroke practice guidelines, update 2015.1 passage
• Cardiac magnetic resonance imaging has limited additional yield in cryptogenic stroke evaluation after transesophageal echocardiography.1 passage
• Cardiac monitoring for detection of atrial fibrillation after TIA: A systematic review and meta-analysis.1 passage
• Cardiorespiratory fitness, cognition and brain structure after TIA or minor ischemic stroke.1 passage
• Care-limiting decisions in acute stroke and association with survival: analyses of UK national quality register data.1 passage
• Carotid artery webs in embolic stroke of undetermined source with large intracranial vessel occlusion.1 passage
• Carotid plaque inflammation assessed with (18)F-FDG PET/CT is higher in symptomatic compared with asymptomatic patients.1 passage
• Carotid revascularization and medical management for asymptomatic carotid stenosis - Hemodynamics (CREST-H): Study design and rationale.1 passage
• Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials.1 passage
• Caveolin-1, Ring finger protein 213, and endothelial function in Moyamoya disease.1 passage
• Central poststroke pain: A systematic review.1 passage
• Cerebellar hemorrhages in patients with Dutch-type hereditary cerebral amyloid angiopathy.1 passage
• Cerebral amyloid angiopathy associated with inflammation: A systematic review of clinical and imaging features and outcome.1 passage
• Cerebral amyloid angiopathy, cerebral microbleeds and implications for anticoagulation decisions: The need for a balanced approach.1 passage
• Cerebral blood volume lesion extent predicts functional outcome in patients with vertebral and basilar artery occlusion.1 passage
• Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019.1 passage
• Cerebral microbleeds development after stroke thrombolysis: A secondary analysis of the THAWS randomized clinical trial.1 passage
• Cerebral microbleeds: Beyond the macroscope.1 passage
• Cerebrolysin dose-dependently improves neurological outcome in rats after acute stroke: A prospective, randomized, blinded, and placebo-controlled study.1 passage
• Cerebrovascular correlates of vitamin D deficiency in older adults living near the Equator: results from the Atahualpa Project.1 passage
• Cerebrovascular disease at young age is related to mother's health during the pregnancy-The Northern Finland Birth Cohort 1966 study.1 passage
• Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature.1 passage
• Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry.1 passage
• Cerebrovascular injury in cryptococcal meningitis.1 passage
• Cerebrovascular reactivity measurement in cerebral small vessel disease: Rationale and reproducibility of a protocol for MRI acquisition and image processing.1 passage
• Cervical artery tortuosity is associated with intracranial aneurysm.1 passage
• Chagas disease is an independent predictor of stroke and death in a cohort of heart failure patients.1 passage
• Changes in stroke incidence, outcome, and associated factors in Porto between 1998 and 2011.1 passage
• Changes in the prevalence of hospitalization and comorbidity in US adults with stroke: A three decade cross-sectional and birth cohort analysis.1 passage
• Changes to volumetric bone mineral density and bone strength after stroke: a prospective study.1 passage
• Characteristics and management of stroke in Korea: 2014-2018 data from Korean Stroke Registry.1 passage
• Characteristics and outcomes of Embolic Stroke of Undetermined Source according to stroke severity.1 passage
• Characteristics and prognosis of patients with embolic stroke of undetermined source in China.1 passage
• Chest infection within 30 days of acute stroke, associated factors, survival and the benefits of stroke unit care: Analysis using linked data from the Australian Stroke Clinical Registry.1 passage
• Children with post-stroke epilepsy have poorer outcomes one year after stroke.1 passage
• Choice of ANesthesia for EndoVAScular Treatment of Acute Ischemic Stroke: Protocol for a randomized controlled (CANVAS) trial.1 passage
• Choroid plexus volume after stroke.1 passage
• Chronic hyperglycemia is related to poor functional outcome after acute ischemic stroke.1 passage
• Cilostazol research in Asia: can it be applied to European and American patients?1 passage
• Cilostazol versus aspirin in ischemic stroke with cerebral microbleeds versus prior intracerebral hemorrhage.1 passage
• Circadian sleep/wake rhythm abnormalities as a risk factor of a poststroke apathy.1 passage
• Circuit class therapy or seven-day week therapy for increasing rehabilitation intensity of therapy after stroke (CIRCIT): a randomized controlled trial.1 passage
• Clinical and cost effectiveness of enhanced oral healthcare in stroke care settings (SOCLE II): a pilot, stepped wedge, cluster randomized, controlled trial protocol.1 passage
• Clinical and neuroimaging criteria to improve the workflow in transfers for endovascular treatment evaluation.1 passage
• Clinical characteristics and outcome of the capsular warning syndrome: a multicenter study.1 passage
• Clinical characteristics of the pregnancies and deliveries of patients with moyamoya disease: A single-center analysis over three decades.1 passage
• Clinical characteristics of unknown symptom onset stroke patients with and without diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch.1 passage
• Clinical effectiveness of endovascular stroke treatment in the early and extended time windows.1 passage
• Clinical features of and risk factors for intracranial aneurysms associated with moyamoya disease.1 passage
• Clinical prediction of thrombectomy eligibility: A systematic review and 4-item decision tree.1 passage
• Clinical results of a new concept of neurothrombectomy coverage at a remote hospital-"drive the doctor".1 passage
• Clinical significance of cerebral microbleeds on MRI: A comprehensive meta-analysis of risk of intracerebral hemorrhage, ischemic stroke, mortality, and dementia in cohort studies (v1).1 passage
• Clinical stroke research in resource limited settings: Tips and hints.1 passage
• Closure of patent foramen ovale in "cryptogenic" stroke: Has the story come to an end?1 passage
• Closure of the patent foramen ovale in patients with embolic stroke of undetermined source: A clinical expert opinion and consensus statement for the Asian-Pacific region.1 passage
• Cognition in stroke rehabilitation and recovery research: Consensus-based core recommendations from the second Stroke Recovery and Rehabilitation Roundtable.1 passage
• Cognitive impact of cerebral microbleeds in patients with symptomatic small vessel disease.1 passage
• Cognitive performance following lacunar stroke in Spanish-speaking patients: results from the SPS3 trial.1 passage
• Collateral flow predicts outcome after basilar artery occlusion: The posterior circulation collateral score.1 passage
• Collaterals 2016: Translating the collaterome around the globe.1 passage
• Combination of intracerebral haemorrhage and familial hypercholesterolemia in the acute hospital setting--a challenge for statin treatment?1 passage
• Combined intravenous and endovascular treatment versus primary mechanical thrombectomy. The Italian Registry of Endovascular Treatment in Acute Stroke.1 passage
• Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial.1 passage
• Comparative effectiveness and safety of edoxaban versus warfarin in patients with atrial fibrillation: A nationwide cohort study.1 passage
• Comparing mismatch strategies for patients being considered for ischemic stroke tenecteplase trials.1 passage
• Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of stroke recurrence and longitudinal progression of white matter lesions and silent brain infarcts on MRI (CEREBRAL study): rationale, design, and methodology.1 passage
• Comparison between voxel-based and subtraction methods for measuring diffusion-weighted imaging lesion growth after thrombolysis.1 passage
• Comparison of MRI IVIM and MR perfusion imaging in acute ischemic stroke due to large vessel occlusion.1 passage
• Comparison of T2*GRE and DSC-PWI for hemorrhage detection in acute ischemic stroke patients: Pooled analysis of the EPITHET, DEFUSE 2, and SENSE 3 stroke studies.1 passage
• Comparison of acute ischemic stroke evaluation and the etiologic subtypes between university and nonuniversity hospitals in Isfahan, Iran.1 passage
• Comparison of mothership versus drip-and-ship models in treating patients with acute ischemic stroke: A systematic review and meta-analysis.1 passage
• Comparison of stroke volume evolution on diffusion-weighted imaging and fluid-attenuated inversion recovery following endovascular thrombectomy.1 passage
• Compensatory intracranial arterial dilatation in extracranial carotid atherosclerosis: the Northern Manhattan study.1 passage
• Complications following incident stroke resulting in readmissions: an analysis of data from three Scottish health surveys.1 passage
• Complications of endovascular treatment for acute ischemic stroke: Prevention and management.1 passage
• Complications of mechanical thrombectomy for acute ischemic stroke: Incidence, risk factors, and clinical relevance in the Italian Registry of Endovascular Treatment in acute stroke.1 passage
• Comprehensive assessment of disability post-stroke using the newly developed miFUNCTION scale.1 passage
• Comprehensive code stroke program to reduce reperfusion delay for in-hospital stroke patients.1 passage
• Computed tomographic angiography in stroke and high-risk transient ischemic attack: Do not leave the emergency department without it!1 passage
• Computed tomography perfusion in stroke mimics.1 passage
• Conceptual framework for establishing the African Stroke Organization.1 passage
• Consistency of associations of systolic and diastolic blood pressure with white matter hyperintensities: A meta-analysis.1 passage
• Constraint-induced or multi-modal personalized aphasia rehabilitation (COMPARE): A randomized controlled trial for stroke-related chronic aphasia.1 passage
• Contemporary prognosis of transient ischemic attack patients: A systematic review and meta-analysis.1 passage
• Contemporary utilization patterns and outcomes of thrombolytic administration for ischemic stroke among patients with cancer.1 passage
• Context is everything: From cardiovascular disease to cerebral microbleeds.1 passage
• Contrast-enhanced ultrasonography for detecting histological carotid plaque rupture: Quantitative analysis of ulcer.1 passage
• Controlled clinical trials of cell therapy in stroke: Meta-analysis at six months after treatment.1 passage
• Controlling Hypertension After Severe Cerebrovascular Event (CHASE): A randomized, multicenter, controlled study.1 passage
• Coronavirus disease 2019 and stroke in Iran: a case series and effects on stroke admissions.1 passage
• Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysis.1 passage
• Cortical superficial siderosis in the general population: The Framingham Heart and Rotterdam studies.1 passage
• Cortical thickness, white matter hyperintensities, and cognition after stroke.1 passage
• Cost of hospitalization for stroke in a low-middle-income country: Findings from a public tertiary hospital in the Philippines.1 passage
• Cost-effectiveness of an enhanced Paramedic Acute Stroke Treatment Assessment (PASTA) during emergency stroke care: Economic results from a pragmatic cluster randomized trial.1 passage
• Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke.1 passage
• Cost-effectiveness of mechanical thrombectomy for acute ischemic stroke in Brazil: Results from the RESILIENT trial.1 passage
• Cost-utility analysis of mechanical thrombectomy between 6 and 24 hours in acute ischemic stroke.1 passage
• Cost-utility analysis of stenting versus endarterectomy in the International Carotid Stenting Study.1 passage
• Costs of bleeding on long-term antiplatelet treatment without routine co-prescription of proton-pump inhibitors.1 passage
• Countries with women inequalities have higher stroke mortality.1 passage
• Countrywide stroke incidence, subtypes, management and outcome in a multiethnic Asian population: the Singapore Stroke Registry--methodology.1 passage
• Cut stroke in half: Polypill for primary prevention in stroke.1 passage
• DEVT: A randomized, controlled, multicenter trial of direct endovascular treatment versus standard bridging therapy for acute stroke patients with large vessel occlusion in the anterior circulation - Protocol.1 passage
• Dabigatran following acute transient ischemic attack and minor stroke II (DATAS II).1 passage
• Daily National Institutes of Health Stroke Scale examinations at stroke centers: why not do them?1 passage
• Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami.1 passage
• Decreased kidney function relates to progression of cerebral microbleeds in lacunar stroke patients.1 passage
• Depression predictors within six months of ischemic stroke: The DEPRESS Study.1 passage
• Depression: cognition relations after stroke.1 passage
• Design and implementation of Pharyngeal electrical Stimulation for early de-cannulation in TRACheotomized (PHAST-TRAC) stroke patients with neurogenic dysphagia: a prospective randomized single-blinded interventional study.1 passage
• Design and implementation of observational studies to measure disease burden with a focus on stroke.1 passage
• Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS).1 passage
• Detecting lenticulostriate artery lesions in patients with acute ischemic stroke using high-resolution MRA at 7 T.1 passage
• Detection of Silent Atrial Fibrillation aFter Ischemic StrOke (SAFFO) guided by implantable loop recorder: multicentre Italian trial based on stroke unit network with paired cardio-arrhythmology units (Italian Neurocardiology Unit Network).1 passage
• Determining optimal poststroke exercise: Study protocol for a randomized controlled trial investigating therapeutic intensity and dose on functional recovery during stroke inpatient rehabilitation.1 passage
• Determining the optimal dose of tenecteplase before endovascular therapy for ischemic stroke (EXTEND-IA TNK Part 2): A multicenter, randomized, controlled study.1 passage
• Diagnosis and management of carotid free-floating thrombus: A systematic literature review.1 passage
• Diagnostic procedures in ischaemic stroke patients with dementia. a population-based study.1 passage
• Differences in outcomes following an intensive upper-limb rehabilitation program for patients with common central nervous system-acting drug prescriptions.1 passage
• Differences in wake-up and unknown onset stroke examined in a stroke registry.1 passage
• Differential characteristics, stroke recurrence, and predictors of covert atrial fibrillation of embolic strokes of undetermined source.1 passage
• Diffusion imaging of cerebral diaschisis in childhood arterial ischemic stroke.1 passage
• Diffusion-weighted imaging lesion growth occurs despite recanalization in acute ischemic stroke: Implications for future treatment trials.1 passage
• Diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with Trevo (DAWN) trial methods.1 passage
• Direct Intra-arterial thrombectomy in order to Revascularize AIS patients with large vessel occlusion Efficiently in Chinese Tertiary hospitals: A Multicenter randomized clinical Trial (DIRECT-MT)-Protocol.1 passage
• Direct mechanical thrombectomy without intravenous thrombolysis versus bridging therapy for acute ischemic stroke: A meta-analysis of randomized controlled trials.1 passage
• Direct medical cost of stroke in Singapore.1 passage
• Discharge educational strategies for reduction of vascular events (DESERVE): design and methods.1 passage
• Disconnectomics: Stroke-related disconnection and dysfunction in distributed brain networks.1 passage
• Discrepancy between post-treatment infarct volume and 90-day outcome in the ESCAPE randomized controlled trial.1 passage
• Distribution and current problems of acute endovascular therapy for large artery occlusion from a two-year national survey in Japan.1 passage
• Do cognitive, language, or physical impairments affect participation in a trial of self-management programs for stroke?1 passage
• Do thrombolysis outcomes differ between anterior circulation stroke and posterior circulation stroke? A systematic review and meta-analysis.1 passage
• Does national expenditure on research and development influence stroke outcomes?1 passage
• Does non-implanted electrical stimulation reduce post-stroke urinary or fecal incontinence? A systematic review with meta-analysis.1 passage
• Does personalized medicine exist and can you test it in a clinical trial?1 passage
• Does prior antiplatelet treatment improve functional outcome after intra-arterial treatment for acute ischemic stroke?1 passage
• Drip-and-ship versus mothership for endovascular treatment of acute stroke: A comparative effectiveness analysis.1 passage
• Driving in stroke survivors aged 18-65 years: The Psychosocial Outcomes In StrokE (POISE) Cohort Study.1 passage
• Durability of the beneficial effect of MLC601 (NeuroAiD™) on functional recovery among stroke patients from the Philippines in the CHIMES and CHIMES-E studies.1 passage
• Dynamic changes of intramural hematoma in patients with acute spontaneous internal carotid artery dissection.1 passage
• Dysphagia in supratentorial recent small subcortical infarcts results from bilateral pyramidal tract damage.1 passage
• Dysphagia screening after intracerebral hemorrhage.1 passage
• Dysphagia screening and risks of pneumonia and adverse outcomes after acute stroke: An international multicenter study.1 passage
• ERic Acute StrokE Recanalization: A study using predictive analytics to assess a new device for mechanical thrombectomy.1 passage
• EXPRESS: A Randomized Controlled Trial to Optimize Patientâs Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT2): Study Protocol.1 passage
• EXPRESS: COVID-19 AND STROKE â UNDERSTANDING THE RELATIONSHIP AND ADAPTING SERVICES. A GLOBAL WORLD STROKE ORGANISATION PERSPECTIVE.1 passage
• Early neurological deterioration after thrombolysis: Clinical and imaging predictors.1 passage
• Early neurological stability predicts adverse outcome after acute ischemic stroke.1 passage
• Early risk of recurrent stroke in patients with symptomatic carotid near-occlusion: Results from CAOS, a multicenter registry study.1 passage
• Early tracheostomy in ventilated stroke patients: Study protocol of the international multicentre randomized trial SETPOINT2 (Stroke-related Early Tracheostomy vs. Prolonged Orotracheal Intubation in Neurocritical care Trial 2).1 passage
• Early-onset delirium after spontaneous intracerebral hemorrhage.1 passage
• Economic Evaluation Plan (EEP) for A Very Early Rehabilitation Trial (AVERT): An international trial to compare the costs and cost-effectiveness of commencing out of bed standing and walking training (very early mobilization) within 24 h of stroke onset with usual stroke unit care.1 passage
• Economic burden of informal care attributable to stroke among those aged 65 years or older in China.1 passage
• Economic evaluation of extended electrocardiogram monitoring for atrial fibrillation in patients with cryptogenic stroke.1 passage
• Economic evaluation of the Melbourne Mobile Stroke Unit.1 passage
• Effect of B-vitamins on stroke risk among individuals with vascular disease who are not on antiplatelets: A meta-analysis.1 passage
• Effect of adding upper limb rehabilitation to botulinum toxin-A on upper limb activity after stroke: Protocol for the InTENSE trial.1 passage
• Effect of addition of clopidogrel to aspirin on stroke incidence: Meta-analysis of randomized trials.1 passage
• Effect of addition of clopidogrel to aspirin on subdural hematoma: meta-analysis of randomized clinical trials.1 passage
• Effect of emergent carotid stenting during endovascular therapy for acute anterior circulation stroke patients with tandem occlusion: A multicenter, randomized, clinical trial (TITAN) protocol.1 passage
• Effect of magnesium treatment and glucose levels on delayed cerebral ischemia in patients with subarachnoid hemorrhage: a substudy of the Magnesium in Aneurysmal Subarachnoid Haemorrhage trial (MASH-II).1 passage
• Effect of renal impairment on the efficacy and safety of intra-arterial treatment: A post-hoc analysis of DIRECT-MT study.1 passage
• Effect of seasonal and temperature variation on hospitalizations for stroke over a 10-year period in Brazil.1 passage
• Effect of ticagrelor with clopidogrel on high on-treatment platelet reactivity in acute stroke or transient ischemic attack (PRINCE) trial: Rationale and design.1 passage
• Effects of SSRI exposure on hemorrhagic complications and outcome following thrombolysis in ischemic stroke.1 passage
• Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials.1 passage
• Effects of blood pressure lowering in patients with acute ischemic stroke and carotid artery stenosis.1 passage
• Effects of candesartan in acute stroke on vascular events during long-term follow-up: results from the Scandinavian Candesartan Acute Stroke Trial (SCAST).1 passage
• Effects of early blood pressure reduction on cognitive function in patients with acute ischemic stroke.1 passage
• Efficacy and safety of endovascular treatment in acute ischemic stroke due to cervical artery dissection: A 15-year consecutive case series.1 passage
• Egyptian experience in increasing utilization of reperfusion therapies in acute ischemic stroke.1 passage
• Elevated C-reactive protein increases diagnostic accuracy of algorithm-defined stroke-associated pneumonia in afebrile patients.1 passage
• Elevated early lesion water uptake in acute stroke predicts poor outcome despite successful recanalization - When "tissue clock" and "time clock" are desynchronized.1 passage
• Elevated platelet-derived growth factor AB/BB is associated with a lower risk of recurrent vascular events in stroke patients.1 passage
• Elevation of cerebrospinal fluid cytokine/chemokines involved in innate, T cell, and granulocyte inflammation in pediatric focal cerebral arteriopathy.1 passage
• Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry.1 passage
• Emotions after stroke: A narrative update.1 passage
• Encephaloduroarteriosynangiosis (EDAS) revascularization for symptomatic intracranial atherosclerotic steno-occlusive (ERSIAS) Phase-II objective performance criterion trial.1 passage
• Endarterectomy vs. stenting vs. medical therapy.1 passage
• Endovascular therapy versus thrombolysis in patients with anterior circulation stroke in everyday clinical practice.1 passage
• Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times (ESCAPE) trial: methodology.1 passage
• Endovascular versus medical therapy for large-vessel anterior occlusive stroke presenting with mild symptoms.1 passage
• Enhancing the alignment of the preclinical and clinical stroke recovery research pipeline: Consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable translational working group.1 passage
• Enlarged perivascular spaces and cerebral small vessel disease.1 passage
• Enlarged perivascular spaces and cognitive impairment after stroke and transient ischemic attack.1 passage
• Epidemiology of stroke in urban northeast China: A population-based study 2018-2019.1 passage
• Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial.1 passage
• Estimating nocturnal stroke onset times by magnetic resonance imaging in the WAKE-UP trial.1 passage
• Etiology and pathogenesis of Moyamoya Disease: An update on disease prevalence.1 passage
• European Cooperative Acute Stroke Study-4: Extending the time for thrombolysis in emergency neurological deficits ECASS-4: ExTEND.1 passage
• European Stroke Organisation (ESO) guidelines for the management of temperature in patients with acute ischemic stroke.1 passage
• Evaluating recanalization of relevant lenticulostriate arteries in acute ischemic stroke using high-resolution MRA at 7T.1 passage
• Evaluation of a score for the prehospital distinction between cerebrovascular disease and stroke mimic patients.1 passage
• Evaluation of the Swedish National Stroke Campaign: A population-based time-series study.1 passage
• Every 15-min delay in recanalization by intra-arterial therapy in acute ischemic stroke increases risk of poor outcome.1 passage
• Evolving ischemic stroke subtypes in 15 years: A hospital-based observational study.1 passage
• Excess stroke incidence in young Aboriginal people in South Australia: Pooled results from two population-based studies.1 passage
• Experimental determination of rupture pressure and stress of adventitia of human middle cerebral arteries.1 passage
• Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection.1 passage
• Extension of therapeutic window in ischemic stroke by selective mismatch imaging.1 passage
• Extent of secondary intraventricular hemorrhage is an independent predictor of outcomes in intracerebral hemorrhage: data from the Helsinki ICH Study.1 passage
• FAmily-Led RehabiliTaTion aftEr Stroke in INDia: the ATTEND pilot study.1 passage
• Factor seven activating protease (FSAP) predicts response to intravenous thrombolysis in acute ischemic stroke.1 passage
• Factors affecting clinical outcome in large-vessel occlusive ischemic strokes.1 passage
• Factors associated with six-month outcome of pediatric stroke.1 passage
• Factors influencing infarct growth including collateral status assessed using computed tomography in acute stroke patients with large artery occlusion.1 passage
• Factors influencing the use of different methods of consent in a randomized acute stroke trial: The Third International Stroke Trial (IST-3).1 passage
• Factors that influence clinicians' decisions to offer intravenous alteplase in acute ischemic stroke patients with uncertain treatment indication: Results of a discrete choice experiment.1 passage
• Factors that may contribute to poor outcome despite good reperfusion after acute endovascular stroke therapy.1 passage
• Factors, trends, and long-term outcomes for stroke patients returning to work: The South London Stroke Register.1 passage
• Fallibility: a new perspective on the ethics of clinical trial enrollment.1 passage
• Family-led rehabilitation in India (ATTEND)-Findings from the process evaluation of a randomized controlled trial.1 passage
• Fatigue after stroke--perspectives and future directions.1 passage
• Feasibility and utility of an integrated medical imaging and informatics smartphone system for management of acute stroke.1 passage
• Feasibility of improving cerebral autoregulation in acute intracerebral hemorrhage (BREATHE-ICH) study: Results from an experimental interventional study.1 passage
• Fibrinolytic for treatment of intraventricular hemorrhage: A meta-analysis and systematic review.1 passage
• First-line use of contact aspiration for thrombectomy versus a stent retriever for recanalization in acute cerebral infarction: The randomized ASTER study protocol.1 passage
• Five-year survival, disability, and recurrence after first-ever stroke in a middle-income country: A population-based study in Joinvile, Brazil.1 passage
• Flat-head positioning increases cerebral blood flow in anterior circulation acute ischemic stroke. A cluster randomized phase IIb trial.1 passage
• Flat-panel detector CT assessment in stroke to reduce times to intra-arterial treatment: A study of multiphase computed tomography angiography in the angiography suite to bypass conventional imaging.1 passage
• Fluoxetine for stroke recovery: Meta-analysis of randomized controlled trials.1 passage
• Frailty and cerebrovascular disease: Concepts and clinical implications for stroke medicine.1 passage
• Frequency and predictors of occult cancer in ischemic stroke: A systematic review and meta-analysis.1 passage
• Frequency of anxiety after stroke: An updated systematic review and meta-analysis of observational studies.1 passage
• Frequency of post-stroke pneumonia: Systematic review and meta-analysis of observational studies.1 passage
• Frequent, short bouts of light-intensity exercises while standing decreases systolic blood pressure: Breaking Up Sitting Time after Stroke (BUST-Stroke) trial.1 passage
• Functional and emotional outcomes after transient ischemic attack: A 12-month prospective controlled cohort study.1 passage
• Gender differences in the association between parental divorce during childhood and stroke in adulthood: findings from a population-based survey.1 passage
• Georeferencing deaths from stroke in São Paulo: an intra-city stroke belt?1 passage
• Ghost infarct core following endovascular reperfusion: A risk for computed tomography perfusion misguided selection in stroke.1 passage
• Glial fibrillary acidic protein for the early diagnosis of intracerebral hemorrhage: Systematic review and meta-analysis of diagnostic test accuracy.1 passage
• Global Stroke Statistics 2019.1 passage
• Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge.1 passage
• Global impact of COVID-19 on stroke care.1 passage
• Global stroke statistics.1 passage
• Global stroke statistics: An update of mortality data from countries using a broad code of "cerebrovascular diseases".1 passage
• Global survey of the diagnostic evaluation and management of cryptogenic ischemic stroke.1 passage
• Global white matter structural integrity mediates the effect of age on ischemic stroke outcomes.1 passage
• Guidelines for treatment of Susac syndrome - An update.1 passage
• Haptoglobin is associated with increased early perihematoma edema progression in spontaneous intracranial hemorrhage.1 passage
• Head position and cerebral blood flow in acute ischemic stroke patients: Protocol for the pilot phase, cluster randomized, Head Position in Acute Ischemic Stroke Trial (HeadPoST pilot).1 passage
• Heart rate and ischemic stroke: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.1 passage
• Heart rate variability and baroreceptor sensitivity in acute stroke: a systematic review.1 passage
• Hematoma Hounsfield units and expansion of intracerebral hemorrhage: A potential marker of hemostatic clot contraction.1 passage
• Hemodynamic correlates of transient cognitive impairment after transient ischemic attack and minor stroke: A transcranial Doppler study.1 passage
• High five-year mortality rates of ischemic stroke subtypes: A prospective cohort study in Brazil.1 passage
• High in-hospital blood pressure variability and severe disability or death in primary intracerebral hemorrhage patients.1 passage
• High levels of von Willebrand factor and low levels of its cleaving protease, ADAMTS13, are associated with stroke in young HIV-infected patients.1 passage
• High prevalence of stroke and uncontrolled associated risk factors are major public health challenges in rural northeast China: A population-based study.1 passage
• High rate of cardiac thrombus diagnosed by adding cardiac imaging in acute stroke computed tomography protocol.1 passage
• High rate of microbleed formation following primary intracerebral hemorrhage.1 passage
• Histologic features of acute thrombi retrieved from stroke patients during mechanical reperfusion therapy.1 passage
• Histological stroke clot analysis after thrombectomy: Technical aspects and recommendations.1 passage
• Home-based, tailored intervention for reducing falls after stroke (FAST): Protocol for a randomized trial.1 passage
• Homocysteine lowering for stroke prevention: Unravelling the complexity of the evidence.1 passage
• Hospital case-volume is associated with case-fatality after aneurysmal subarachnoid hemorrhage.1 passage
• Hospitalized with stroke at the weekend: Higher cost and risk of early death?1 passage
• How can the World Stroke Organization (WSO) optimize education in stroke medicine around the world? Report of the 2018 WSO Global Stroke Stakeholder Workshop.1 passage
• How do neurologists diagnose transient ischemic attack: A systematic review.1 passage
• How do treatment times impact on functional outcome in stroke patients undergoing thrombectomy in Germany? Results from the German Stroke Registry.1 passage
• How to do a systematic review.1 passage
• How to do health services research in stroke: A focus on performance measurement and quality improvement.1 passage
• How to do high-quality clinical research 1: First steps.1 passage
• Hyperlipidemia is associated with lower risk of poststroke mortality independent of statin use: A population-based study.1 passage
• Hyponatremia predicts mortality after stroke.1 passage
• Hypoperfusion in lenticulostriate arteries territory related to unexplained early neurological deterioration after intravenous thrombolysis.1 passage
• ICARUSS, the Integrated Care for the Reduction of Secondary Stroke trial: rationale and design of a randomized controlled trial of a multimodal intervention to prevent recurrent stroke in patients with a recent cerebrovascular event, ACTRN = 12611000264987.1 passage
• ICARUSS: An effective model for risk factor management in stroke survivors.1 passage
• IER-START nomogram for prediction of three-month unfavorable outcome after thrombectomy for stroke.1 passage
• INFOMATAS multi-center systematic review and meta-analysis individual patient data of dynamic cerebral autoregulation in ischemic stroke.1 passage
• IRMA study: Prevalence of subdiaphragmatic visceral infarction in ischemic stroke and atrial fibrillation.1 passage
• Identification of imaging selection patterns in acute ischemic stroke patients and the influence on treatment and clinical trial enrollment decision making.1 passage
• Identification of patients with embolic stroke of undetermined source and low risk of new incident atrial fibrillation: The AF-ESUS score.1 passage
• Identifying the predictors of first-pass effect and its influence on clinical outcome in the setting of endovascular thrombectomy for acute ischemic stroke: Results from a multicentric prospective registry.1 passage
• Idiopathic primary intraventricular hemorrhage and cerebral small vessel disease.1 passage
• Imaging of occlusive thrombi in acute ischemic stroke.1 passage
• Imaging selection for acute stroke intervention.1 passage
• Imaging selection in ischemic stroke: feasibility of automated CT-perfusion analysis.1 passage
• Immunity and stroke, the hurdles of stroke research translation.1 passage
• Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain.1 passage
• Impact of atrial fibrillation on inpatient cost for ischemic stroke in the USA.1 passage
• Impact of general anesthesia on posterior circulation large vessel occlusions after endovascular thrombectomy.1 passage
• Impact of initial symptom for accurate diagnosis of vertebral artery dissection.1 passage
• Impact of intravenous thrombolysis on functional outcome in patients with mild ischemic stroke without large vessel occlusion or rapidly improving symptoms.1 passage
• Impact of multimorbidity on risk and outcome of stroke: Lessons from chronic kidney disease.1 passage
• Impact of prehospital stroke code in a public center in Paraguay: A pilot study.1 passage
• Impact of previous stroke on outcome after thrombectomy in patients with large vessel occlusion.1 passage
• Impact of renal impairment on short-term outcomes following endovascular thrombectomy for acute ischemic stroke: A systematic review and meta-analysis.1 passage
• Impact of simulation training on a telestroke network.1 passage
• Impact of stroke center certification on rt-PA thrombolysis after acute ischemic stroke in South China from 2015 to 2020.1 passage
• Impact of stroke education on middle school students and their parents: A cluster randomized trial.1 passage
• Implementing the Proclamation of Stroke and Potentially Preventable Dementias.1 passage
• Implications of stroke for caregiver outcomes: findings from the ASPIRE-S study.1 passage
• Improved ischemic stroke outcome prediction using model estimation of outcome probability: the THRIVE-c calculation.1 passage
• Improved survival of patients with warfarin-associated intracerebral haemorrhage: a retrospective longitudinal population-based study.1 passage
• Improving care for acute in-hospital ischemic strokes-A narrative review.1 passage
• Improving life after stroke needs global efforts to implement evidence-based physical activity pathways.1 passage
• Improving quality and outcomes of stroke care in hospitals: Protocol and statistical analysis plan for the Stroke123 implementation study.1 passage
• Improving the development, monitoring and reporting of stroke rehabilitation research: Consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable.1 passage
• Incidence and risk factors for stroke following percutaneous coronary intervention.1 passage
• Incidence and risk factors of intracranial aneurysm: A national cohort study in Korea.1 passage
• Incidence of atrial fibrillation among patients with an embolic stroke of undetermined source: Insights from insertable cardiac monitors.1 passage
• Incidence of first stroke and ethnic differences in stroke pattern in Bradford, UK: Bradford Stroke Study.1 passage
• Incidence of seizure in stroke patients treated with recombinant tissue plasminogen activator: A systematic review and meta-analysis.1 passage
• Incidence, clinical features and outcomes of atrial fibrillation and stroke in Qatar.1 passage
• Incidence, predictors, and etiology of subsequent ischemic stroke within one year after transient ischemic attack.1 passage
• Incidence, recurrence, and long-term survival of ischemic stroke subtypes: A population-based study in the Middle East.1 passage
• Income inequalities and stroke mortality trends in Sao Paulo, Brazil, 1996-2011.1 passage
• Individual patient data meta-analysis of antiplatelet regimens after noncardioembolic stroke or TIA: rationale and design.1 passage
• Infarct location is associated with quality of life after mild ischemic stroke.1 passage
• Inflammatory cytokines, high-sensitivity C-reactive protein, and risk of one-year vascular events, death, and poor functional outcome after stroke and transient ischemic attack.1 passage
• Inflammatory markers and their association with post stroke cognitive decline.1 passage
• Influence of improvement or worsening of glucose tolerance on risk of stroke in persons with impaired glucose tolerance.1 passage
• Influence of stroke coordinators on delivery of acute stroke care and hospital outcomes: An observational study.1 passage
• Influence of time to endovascular stroke treatment on outcomes in the early versus extended window paradigms.1 passage
• Informal caregivers in stroke: Life impact, support, and psychological well-being-A Swedish Stroke Register (Riksstroke) study.1 passage
• Inpatient stroke care quality for veterans: are there differences between Veterans Affairs medical centers in the stroke belt and other areas?1 passage
• Intakes of magnesium, potassium, and calcium and the risk of stroke among men.1 passage
• Intensive blood pressure lowering with nicardipine and outcomes after intracerebral hemorrhage: An individual participant data systematic review.1 passage
• Inter-rater agreement analysis of the Precise Diagnostic Score for suspected transient ischemic attack.1 passage
• Interactive effects of physical fitness and body mass index on risk of stroke: A national cohort study.1 passage
• Intermediate risk of cardiac events and recurrent stroke after stroke admission in young adults.1 passage
• International stroke genetics consortium recommendations for studies of genetics of stroke outcome and recovery.1 passage
• International survey of acute stroke imaging used to make revascularization treatment decisions.1 passage
• International translation of Fever, Sugar, Swallow Protocols: The Quality in Acute Stroke Care Europe Project.1 passage
• Internet-based information-seeking behavior for transient ischemic attack.1 passage
• Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial.1 passage
• Intra-arterial thrombolysis vs. standard treatment or intravenous thrombolysis in adults with acute ischemic stroke: a systematic review and meta-analysis.1 passage
• Intracranial arterial wall imaging: Techniques, clinical applicability, and future perspectives.1 passage
• Intracranial atherosclerosis: From anatomy to pathophysiology.1 passage
• Intracranial plaque enhancement from high resolution vessel wall magnetic resonance imaging predicts stroke recurrence.1 passage
• Intravenous administration of tirofiban versus loading dose of oral clopidogrel for preventing thromboembolism in stent-assisted coiling of intracranial aneurysms.1 passage
• Intravenous alteplase versus rescue endovascular procedure in patients with proximal middle cerebral artery occlusion.1 passage
• Intravenous thrombolysis in stroke with admission NIHSS score 0 or 1.1 passage
• Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: Protocol for a randomized, placebo-controlled trial.1 passage
• Is acute reperfusion therapy safe in acute ischemic stroke patients who harbor unruptured intracranial aneurysm?1 passage
• Is breathing our polluted air a risk factor for stroke?1 passage
• Is more physiotherapy better after stroke?1 passage
• Ischemic involvement of the primary motor cortex is a prognostic factor in acute stroke.1 passage
• Isolated punctuate hippocampal infarction and transient global amnesia are indistinguishable by means of MRI.1 passage
• Kidney function and cerebral small vessel disease in the general population.1 passage
• Knowledge, attitudes and practices of West Africans on genetic studies of stroke: Evidence from the SIREN Study.1 passage
• Left ventricular wall motion abnormality is associated with cryptogenic stroke.1 passage
• Let's call it "aphasia": Rationales for eliminating the term "dysphasia".1 passage
• Leucocyte count in young adults with first-ever ischaemic stroke: associated factors and association on prognosis.1 passage
• Leukoaraiosis and lacunes are associated with poor clinical outcomes in ischemic stroke patients treated with intravenous thrombolysis.1 passage
• Life-threatening coronary disease is prevalent in patients with stenosing carotid artery disease.1 passage
• Location of cerebral atherosclerosis: Why is there a difference between East and West?1 passage
• Location-specific differences in hematoma volume predict outcomes in patients with spontaneous intracerebral hemorrhage.1 passage
• Logistical and financial obstacles for endovascular therapy of acute stroke implementation.1 passage
• Long-term (>10-year) clinical follow-up after young embolic stroke/TIA of undetermined source.1 passage
• Long-term cost-effectiveness of thrombectomy for acute ischaemic stroke in real life: An analysis based on data from the Swedish Stroke Register (Riksstroke).1 passage
• Long-term disability after stroke in Iran: Evidence from the Mashhad Stroke Incidence Study.1 passage
• Long-term monitoring to detect atrial fibrillation with the indwelling implantable cardiac monitors.1 passage
• Long-term mortality in patients with coexisting potential causes of ischemic stroke.1 passage
• Long-term mortality in survivors of spontaneous intracerebral hemorrhage.1 passage
• Long-term neurobehavioral correlates of brain cortical microinfarcts in a memory clinic cohort in Singapore.1 passage
• Long-term neurological, vascular, and mortality outcomes after stroke.1 passage
• Long-term predictors of stroke in healthy middle-aged men.1 passage
• Long-term stroke incidence in proximal thoracic aorta aneurysm survivors.1 passage
• Longer term patient management following stroke: A systematic review.1 passage
• Look closer: The multidimensional patterns of post-stroke burden behind the modified Rankin Scale.1 passage
• Low flow in the left atrial appendage assessed by transesophageal echocardiography is associated with increased stroke severity-Results of a single-center cross-sectional study.1 passage
• Low-density lipoprotein cholesterol lowering for the prevention of cardiovascular outcomes in patients with ischemic stroke.1 passage
• Low-dose versus standard-dose alteplase in acute ischemic stroke in Asian stroke registries: an individual patient data pooling study.1 passage
• Magnetic resonance imaging and brain injury in the chronic phase after aneurysmal subarachnoid hemorrhage: A systematic review.1 passage
• Magnetic resonance imaging-based endovascular versus medical stroke treatment for symptom onset up to 12 h.1 passage
• Malignant infarction after endovascular treatment: Incidence and prediction.1 passage
• Management of acute central retinal artery occlusion: Intravenous thrombolysis is feasible and safe.1 passage
• Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel.1 passage
• Management of ischemic stroke in Central and Eastern Europe.1 passage
• Management of oral anticoagulation after intracerebral hemorrhage.1 passage
• Management of transient ischemic attacks diagnosed by early-career general practitioners: A cross-sectional study.1 passage
• Measuring non-vitamin K antagonist oral anticoagulant levels: When is it appropriate and which methods should be used?1 passage
• Measuring stroke and transient ischemic attack burden in New Zealand: Protocol for the fifth Auckland Regional Community Stroke Study (ARCOS V).1 passage
• Measuring the effects of listening for leisure on outcome after stroke (MELLO): A pilot randomized controlled trial of mindful music listening.1 passage
• Mechanical thrombectomy in acute ischemic stroke: Consensus statement by ESO-Karolinska Stroke Update 2014/2015, supported by ESO, ESMINT, ESNR and EAN.1 passage
• Mechanical thrombectomy in patients with acute ischemic stroke: A cost-effectiveness and value of implementation analysis.1 passage
• Mechanisms of action of acute and subacute sphenopalatine ganglion stimulation for ischemic stroke.1 passage
• Medicare claims indicators of healthcare utilization differences after hospitalization for ischemic stroke: Race, gender, and caregiving effects.1 passage
• Metabolic syndrome identifies normal weight insulin-resistant stroke patients at risk for recurrent vascular disease.1 passage
• Methodology of the fatigue after stroke educational recovery group randomized controlled trial.1 passage
• Methods to improve patient recruitment and retention in stroke trials.1 passage
• Missing voices: Profile and extent of acquired communication disorders in Aboriginal and non-Aboriginal adult stroke survivors in Western Australia using linked administrative records.1 passage
• Mobile stroke unit versus standard medical care in the management of patients with acute stroke: A systematic review and meta-analysis.1 passage
• Modest blood pressure reduction with valsartan in acute ischemic stroke: a prospective, randomized, open-label, blinded-end-point trial.1 passage
• Modified Rankin scale as a determinant of direct medical costs after stroke.1 passage
• Morphological MRI characteristics of recent small subcortical infarcts.1 passage
• Morphological classification of penetrating artery pontine infarcts and association with risk factors and prognosis: The SPS3 trial.1 passage
• Moving rehabilitation research forward: Developing consensus statements for rehabilitation and recovery research.1 passage
• Moving stroke rehabilitation research evidence into clinical practice: Consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable.1 passage
• Moyamoya vasculopathy - Patient demographics and characteristics in the Finnish population.1 passage
• Multi-level community interventions for primary stroke prevention: A conceptual approach by the World Stroke Organization.1 passage
• Multi-modal CT in acute stroke: wait for a serum creatinine before giving intravenous contrast? No!1 passage
• NLRP3 inflammasome in ischemic stroke: As possible therapeutic target.1 passage
• National Institutes of Health Stroke Scale score is an unreliable predictor of perfusion deficits in acute stroke.1 passage
• National and sub-national patterns of mortality from stroke in the Iranian population (1990-2015): Complementary results from the NASBOD study.1 passage
• National stroke registries for monitoring and improving the quality of hospital care: A systematic review.1 passage
• National trends in hospital admission, case fatality, and sex differences in atrial fibrillation-related strokes.1 passage
• National trends in outcomes of ischemic stroke and prognostic influence of stroke center capability in Japan, 2010-2016.1 passage
• Natural history of nonbacterial thrombotic endocarditis treated with warfarin.1 passage
• Neighborhood socioeconomic status and the prevalence of stroke and coronary heart disease in rural China: a population-based study.1 passage
• Neighborhood socioeconomic status at the age of 40 years and ischemic stroke before the age of 50 years: A nationwide cohort study from Sweden.1 passage
• Neural correlates of cricopharyngeal dysfunction after supratentorial stroke: A voxel-based lesion-symptom mapping with propensity score matched case-control.1 passage
• Neurothrombectomy trial results: stroke systems, not just devices, make the difference.1 passage
• New opportunities to optimize antithrombotic therapy for secondary stroke prevention.1 passage
• No benefits of hypothermia in patients treated with hemicraniectomy for large ischemic stroke.1 passage
• No sex differences in long-term functional outcome after intracerebral hemorrhage.1 passage
• Non-contrast head CT-based thrombolysis for wake-up/unknown onset stroke is safe: A single-center study and meta-analysis.1 passage
• Non-invasive sensor technology for prehospital stroke diagnosis: Current status and future directions.1 passage
• Noncontrast Computed Tomography Markers of Cerebral Hemorrhage Expansion: Diagnostic Accuracy Meta-Analysis.1 passage
• Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials.1 passage
• Normal-appearing white matter microstructural injury is associated with white matter hyperintensity burden in acute ischemic stroke.1 passage
• Nosocomial infections after aneurysmal subarachnoid hemorrhage: time course and causative pathogens.1 passage
• Novel TIA biomarkers identified by mass spectrometry-based proteomics.1 passage
• Novel oral anticoagulant management issues for the stroke clinician.1 passage
• Number needed to screen for acute revascularization trials in stroke: Prognostic and predictive imaging biomarkers.1 passage
• Occlusion site does not impact outcome in patients with carotid stroke undergoing endovascular reperfusion.1 passage
• Off-hour effect on time metrics and clinical outcomes in endovascular treatment for large vessel occlusion: A systematic review and meta-analysis.1 passage
• One decade of oral anticoagulation in stroke patients: Results from a large country-wide hospital-based registry.1 passage
• One-year case fatality rate following stroke in the Mashhad Stroke Incidence Study: a population-based study of stroke in Iran.1 passage
• One-year disability, death and recurrence after first-ever stroke in a Black Afro-Caribbean population.1 passage
• Optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation (START): Methodology of a pragmatic, response-adaptive, prospective randomized clinical trial.1 passage
• Optimal medical treatment versus carotid endarterectomy: the rationale and design of the Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis (AMTEC) study.1 passage
• Oral anticoagulation improves survival in very elderly Chinese patients with atrial fibrillation: A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.1 passage
• Oral anticoagulation versus antiplatelet or placebo for stroke prevention in patients with heart failure and sinus rhythm: Systematic review and meta-analysis of randomized controlled trials.1 passage
• Oral direct thrombin inhibitor as an alternative in the management of cerebral venous thrombosis: a series of 15 patients.1 passage
• Organization of Stroke Care in Pakistan.1 passage
• Organization of stroke care in Turkey.1 passage
• Outcome after intravenous thrombolysis in patients with acute lacunar stroke: An observational study based on SITS international registry and a meta-analysis.1 passage
• Outcome in Patients Treated with Intra-arterial thrombectomy: The optiMAL Blood Pressure control (OPTIMAL-BP) Trial.1 passage
• Outcome in patients admitted outside regular hospital working hours: does time until regular working hours matter?1 passage
• Outcomes after stroke thrombolysis according to prior antiplatelet use.1 passage
• Overcoming global challenges in stroke prophylaxis in atrial fibrillation: The role of non-vitamin K antagonist oral anticoagulants.1 passage
• Overview of endovascular thrombectomy accessibility gap for acute ischemic stroke in Asia: A multi-national survey.1 passage
• POST-NOAC: Portuguese observational study of intracranial hemorrhage on non-vitamin K antagonist oral anticoagulants.1 passage
• Palliative care after stroke: A review.1 passage
• Paracetamol (Acetaminophen) in stroke 2 (PAIS 2): protocol for a randomized, placebo-controlled, double-blind clinical trial to assess the effect of high-dose paracetamol on functional outcome in patients with acute stroke and a body temperature of 36.5 °C or above.1 passage
• Parenchymatous hematoma in patients with atraumatic subarachnoid hemorrhage: Characteristics, treatment, and clinical outcomes.1 passage
• Partitioning risk factors for embolic stroke of undetermined source using exploratory factor analysis.1 passage
• Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study.1 passage
• Patient refusal of thrombolytic therapy for suspected acute ischemic stroke.1 passage
• Patient-specific prediction of functional recovery after stroke.1 passage
• Patterns of ischemic posterior circulation strokes: A clinical, anatomical, and radiological review.1 passage
• Penumbra and re-canalization acute computed tomography in ischemic stroke evaluation: PRACTISE study protocol.1 passage
• Performance evolution over 645 acute stroke thrombectomies in a public Brazilian healthcare institution.1 passage
• Performance of e-ASPECTS software in comparison to that of stroke physicians on assessing CT scans of acute ischemic stroke patients.1 passage
• Performance of short ECG recordings twice daily to detect paroxysmal atrial fibrillation in stroke and transient ischemic attack patients.1 passage
• Perfusion imaging and recurrent cerebrovascular events in intracranial atherosclerotic disease or carotid occlusion.1 passage
• Perivascular spaces and their associations with risk factors, clinical disorders and neuroimaging features: A systematic review and meta-analysis.1 passage
• Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions.1 passage
• Phone-based intervention for blood pressure control among Ghanaian stroke survivors: A pilot randomized controlled trial.1 passage
• Physical Fitness Training in Patients with Subacute Stroke (PHYS-STROKE): Safety analyses of a randomized clinical trial.1 passage
• Physical inactivity is a strong risk factor for stroke in the oldest old: Findings from a multi-ethnic population (the Northern Manhattan Study).1 passage
• Pittsburgh response to endovascular therapy score as a pre-treatment prognostic tool: External validation in Trevo2.1 passage
• Platelet glycoprotein gene Ia C807T, HPA-3, and Ibα VNTR polymorphisms are associated with increased ischemic stroke risk: Evidence from a comprehensive meta-analysis.1 passage
• Poor utility of grading scales in acute intracerebral hemorrhage: results from the INTERACT2 trial.1 passage
• Post-stroke cognitive impairment on the Mini-Mental State Examination primarily relates to left middle cerebral artery infarcts.1 passage
• Post-stroke depression, obstructive sleep apnea, and cognitive impairment: Rationale for, and barriers to, routine screening.1 passage
• Post-stroke dysphagia: A review and design considerations for future trials.1 passage
• Post-stroke fatigue is associated with resting state posterior hypoactivity and prefrontal hyperactivity.1 passage
• Post-stroke infections and preventive antibiotics in stroke: Update of clinical evidence.1 passage
• Post-stroke social networks, depressive symptoms, and disability in Tanzania: A prospective study.1 passage
• Posterior circulation collateral flow modifies the effect of thrombectomy on outcome in acute basilar artery occlusion.1 passage
• Posterior circulation stroke due to vertebral artery disease in the Chinese population.1 passage
• Posterior circulation stroke is associated with prolonged door-to-needle time.1 passage
• Posterior vs. anterior circulation infarction: demography, outcomes, and frequency of hemorrhage after thrombolysis.1 passage
• Poststroke anxiety is prevalent at the population level, especially among socially deprived and younger age community stroke survivors.1 passage
• Poststroke fatigue: risk factors and its effect on functional status and health-related quality of life.1 passage
• Poststroke shoulder pain in subacute patients and its correlation with upper limb recovery after robotic or conventional treatment: A secondary analysis of a multicenter randomized controlled trial.1 passage
• Potential gains and costs from increasing access to thrombolysis for acute ischemic stroke patients in New Zealand hospitals.1 passage
• Potential link between post-acute ischemic stroke exposure to hypoglycemia and hemorrhagic transformation.1 passage
• Pre-existing Comorbidity Burden and Patient Perceived Stroke Impact.1 passage
• Pre-stroke physical activity and admission stroke severity: A systematic review.1 passage
• Preceding infection and risk of stroke: An old concept revived by the COVID-19 pandemic.1 passage
• Predicting post-stroke cognitive impairment using acute CT neuroimaging: A systematic review and meta-analysis.1 passage
• Predicting specific abilities after disabling stroke: Development and validation of prognostic models.1 passage
• Prediction of intracerebral haemorrhage expansion with clinical, laboratory, pharmacologic, and noncontrast radiographic variables.1 passage
• Prediction of recanalization in acute stroke patients receiving intravenous and endovascular revascularization therapy.1 passage
• Predictive impact of daily physical activity on new vascular events in patients with mild ischemic stroke.1 passage
• Predictive validity of severity grading for cerebral steno-occlusive arteriopathy in recurrent childhood ischemic stroke.1 passage
• Predictors of delayed stroke in patients with cervical artery dissection.1 passage
• Prehemorrhage antiplatelet use in aneurysmal subarachnoid hemorrhage and impact on clinical outcome.1 passage
• Prehospital idarucizumab prior to intravenous thrombolysis in a mobile stroke unit.1 passage
• Prevalence and cognitive impact of medial temporal atrophy in a hospital stroke service: retrospective cohort study.1 passage
• Prevalence of stroke in Argentina: A door-to-door population-based study (EstEPA).1 passage
• Prevalence of stroke symptoms among stroke-free residents: first national data from Lebanon.1 passage
• Prevalence of vertebral artery origin stenosis in a multirace-ethnic posterior circulation stroke cohort: Miami Stroke Registry (MIAMISR).1 passage
• Prevalence, prognosis, and treatment of atherosclerotic intracranial stenosis in Caucasians.1 passage
• Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combination.1 passage
• Prevention of poststroke cognitive decline: ASPIS--a multicenter, randomized, observer-blind, parallel group clinical trial to evaluate multiple lifestyle interventions--study design and baseline characteristics.1 passage
• Preventive effects of multiple domain interventions on lifestyle and risk factor changes in stroke survivors: Evidence from a two-year randomized trial.1 passage
• Preventive screening for intracranial aneurysms.1 passage
• Primary intraventricular hemorrhage outcomes in the CLEAR III trial.1 passage
• Primary prevention of stroke and cardiovascular disease in the community (PREVENTS): Methodology of a health wellness coaching intervention to reduce stroke and cardiovascular disease risk, a randomized clinical trial.1 passage
• Primary stroke prevention needs overhaul.1 passage
• Primary to comprehensive stroke center transfers: Appropriateness, not futility.1 passage
• Prior antiplatelet agent use and outcomes after intravenous thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: a meta-analysis of cohort studies and randomized controlled trials.1 passage
• Prior antiplatelet therapy in patients undergoing endovascular treatment for acute ischemic stroke: Results from the MR CLEAN Registry.1 passage
• Prior stroke and transient ischemic attack as risk factors for subsequent stroke in atrial fibrillation patients: A report from the GARFIELD-AF registry.1 passage
• Prognostic importance of weight change on short-term functional outcome in acute ischemic stroke.1 passage
• Prognostic significance of early urinary catheterization after acute stroke: Secondary analyses of the international HeadPoST trial.1 passage
• Prognostic value of 24-h ABPM in acute ischemic stroke for short-, medium-, and long-term outcome: a systematic review and meta-analysis.1 passage
• Prophylactic heparin in acute intracerebral hemorrhage: a propensity score-matched analysis of the INTERACT2 study.1 passage
• Prospective Randomized Open-label Trial to evaluate risk faCTor management in patients with Unruptured intracranial aneurysms: Study protocol.1 passage
• Proteinuria as an independent predictor of stroke: Systematic review and meta-analysis.1 passage
• Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.1 passage
• Protocol for a prospective collaborative systematic review and meta-analysis of individual patient data from randomized controlled trials of vasoactive drugs in acute stroke: The Blood pressure in Acute Stroke Collaboration, stage-3.1 passage
• Protocol for the MAnagement of Systolic blood pressure during Thrombectomy by Endovascular Route for acute ischemic STROKE randomized clinical trial: The MASTERSTROKE trial.1 passage
• Protocol for the comparison of triflusal and clopidogrel in secondary prevention of stroke based on cytochrome P450 2C19 genotyping (MASETRO study): A multicenter, randomized, open-label, parallel-group trial.1 passage
• Protocol for the perfusion and angiography imaging sub-study of the Third International Stroke Trial (IST-3) of alteplase treatment within six-hours of acute ischemic stroke.1 passage
• Protocol of a cluster randomized trial evaluation of a patient and carer-centered system of longer-term stroke care (LoTS care).1 passage
• Protocol of a randomized controlled trial investigating the effectiveness of Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke (ReCAPS).1 passage
• Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011.1 passage
• Quality of life after intra-arterial treatment for acute ischemic stroke in the MR CLEAN trial-Update.1 passage
• Quality of life after surgical decompression for space-occupying middle cerebral artery infarction: systematic review.1 passage
• Quality-of-care comparison of stroke: The reliability and robustness of ranking by process or outcome measures.1 passage
• REVASCAT: a randomized trial of revascularization with SOLITAIRE FR device vs. best medical therapy in the treatment of acute stroke due to anterior circulation large vessel occlusion presenting within eight-hours of symptom onset.1 passage
• Racial/ethnic disparities in hospital utilization in intracerebral hemorrhage.1 passage
• Radiosurgical, neurosurgical, or no intervention for cerebral cavernous malformations: A decision analysis.1 passage
• Randomization of endovascular treatment with stent-retriever and/or thromboaspiration versus best medical therapy in acute ischemic stroke due to large vessel occlusion trial: Rationale and design.1 passage
• Rationale and design of Triple AXEL: trial for early anticoagulation in acute ischemic stroke patients with nonvalvular atrial fibrillation.1 passage
• Rationale and design of a phase 3b, prospective, randomized, open label, blinded-endpoint, multicenter trial of the efficacy and safety of urokinase thrombolysis comparing with antiplatelet agents for patients with minor stroke.1 passage
• Rationale and design of combination of an immune modulator Fingolimod with Alteplase bridging with Mechanical Thrombectomy in Acute Ischemic Stroke (FAMTAIS) trial.1 passage
• Rationale and design of the PreventIon of CArdiovascular events in iSchemic Stroke patients with high risk of cerebral hemOrrhage (PICASSO) study: A randomized controlled trial.1 passage
• Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial.1 passage
• Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.1 passage
• Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosis.1 passage
• Recanalization after cerebral venous thrombosis. A randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous and dural sinus thrombosis.1 passage
• Recanalization following Endovascular treatment and imaging of PErfusion, Regional inFarction and atrophy to Understand Stroke Evolution-NA1 (REPERFUSE-NA1).1 passage
• Recent advances in carotid angioplasty and stenting.1 passage
• Recent developments and new frontiers in childhood arterial ischemic stroke.1 passage
• Reclassifications of ischemic stroke patterns due to variants of the Circle of Willis.1 passage
• Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial.1 passage
• Recommendations for lipid modification in patients with ischemic stroke or transient ischemic attack: A clinical guide by the Hellenic Stroke Organization and the Hellenic Atherosclerosis Society.1 passage
• RecoverNow: A patient perspective on the delivery of mobile tablet-based stroke rehabilitation in the acute care setting.1 passage
• Reduced risk of poststroke pneumonia in thrombolyzed stroke patients with continued statin treatment.1 passage
• Refining the ischemic penumbra with topography.1 passage
• Regional differences in ischemic stroke in India (north vs. south).1 passage
• Regional, sex, and age differences in diagnostic testing among participants in the NAVIGATE-ESUS trial.1 passage
• Regulation and governance of multinational drug trials in stroke: barriers and possibilities.1 passage
• Relation between physical activity and cerebral small vessel disease: A nine-year prospective cohort study.1 passage
• Relationship between hospital volume and early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator.1 passage
• Relationship between race and outcome in Asian, Black, and Caucasian patients with spontaneous intracerebral hemorrhage: Data from the Virtual International Stroke Trials Archive and Efficacy of Nitric Oxide in Stroke trial.1 passage
• Relative risk of hemorrhage during pregnancy in patients with brain arteriovenous malformations.1 passage
• Reliability of intracerebral hemorrhage classification systems: A systematic review.1 passage
• Remote ischemic conditioning for acute moderate ischemic stroke (RICAMIS): Rationale and design.1 passage
• Remote limb ischemic conditioning treatment for intracranial atherosclerotic stenosis patients.1 passage
• Renal dysfunction and chronic kidney disease in ischemic stroke and transient ischemic attack: A population-based study.1 passage
• Reply from Lynch et al. to letter from Vedpathak and Shah regarding 'When should physical rehabilitation commence after stroke: a systematic review'.1 passage
• Reply from Schönenberger et al. to the letter from Kofke and Sharma regarding "Sedation vs. Intubation for Endovascular Stroke TreAtment (SIESTA) - a randomized monocentric trial".1 passage
• Return to work after young stroke: A systematic review.1 passage
• Review and prioritization of stroke research recommendations to address the mission of the World Stroke Organization: a call to action from the WSO Research Committee.1 passage
• Revised intracerebral hemorrhage expansion definitions: Relationship with care limitations.1 passage
• Revisiting cerebral postischemic reperfusion injury: new insights in understanding reperfusion failure, hemorrhage, and edema.1 passage
• Revisiting promising preclinical intracerebral hemorrhage studies to highlight repurposable drugs for translation.1 passage
• Right-to-left shunt detection sensitivity with air-saline and air-succinil gelatin transcranial Doppler.1 passage
• Risk factors and outcomes of intravenous tissue plasminogen activator and endovascular thrombectomy utilization amongst pediatrics acute ischemic stroke.1 passage
• Risk factors for delayed-onset dementia after stroke or transient ischemic attack-A five-year longitudinal cohort study.1 passage
• Risk factors for ischemic stroke and its subtypes in Chinese vs. Caucasians: Systematic review and meta-analysis.1 passage
• Risk of early recurrent stroke in symptomatic carotid stenosis after best medical therapy and before endarterectomy.1 passage
• Risk of incident ischemic stroke according to the metabolic health and obesity states in the Vascular-Metabolic CUN cohort.1 passage
• Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy.1 passage
• STroke imAging pRevention and treatment (START): A longitudinal stroke cohort study: Clinical trials protocol.1 passage
• SWIFT DIRECT: Solitaire™ With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire™ Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke: Methodology of a randomized, controlled, multicentre study.1 passage
• Safety and early outcomes after intravenous thrombolysis in acute ischemic stroke patients with prestroke disability.1 passage
• Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388).1 passage
• Safety and efficacy of low-dose aspirin in ischemic stroke patients with different G6PD conditions.1 passage
• Safety and efficacy of remote ischemic conditioning for the treatment of intracerebral hemorrhage: A proof-of-concept randomized controlled trial.1 passage
• Safety and feasibiLIty of Metformin in patients with Impaired glucose Tolerance and a recent TIA or minor ischemic stroke (LIMIT) trial - a multicenter, randomized, open-label phase II trial.1 passage
• Safety and outcomes of mechanical thrombectomy for acute stroke related to infective endocarditis: A case-control study.1 passage
• Safety and predictors of stroke mimics in The Norwegian Tenecteplase Stroke Trial (NOR-TEST).1 passage
• Safety of antithrombotic therapy for patients with acute ischemic stroke harboring unruptured intracranial aneurysm.1 passage
• Safety of endovascular treatment in acute stroke patients taking oral anticoagulants.1 passage
• Salvage of the PWI/DWI mismatch up to 48 h from stroke onset leads to favorable clinical outcome.1 passage
• Secondary Prevention by Structured Semi-Interactive Stroke Prevention Package in India (SPRINT INDIA) study protocol.1 passage
• Sedation vs. Intubation for Endovascular Stroke TreAtment (SIESTA) - a randomized monocentric trial.1 passage
• Sedentary behavior after stroke: A new target for therapeutic intervention.1 passage
• Selection for delayed intravenous alteplase treatment based on a prognostic score.1 passage
• Semi-automatic measurement of intracranial hemorrhage growth on non-contrast CT.1 passage
• Setting performance benchmarks for stroke care delivery: Which quality indicators should be prioritized in quality improvement; an analysis in 500,331 stroke admissions.1 passage
• Setting the scene for the Second Stroke Recovery and Rehabilitation Roundtable.1 passage
• Setting up a Neuroscience Stroke and Rehabilitation Centre in Brunei Darussalam by a transcontinental on-site and telemedical cooperation.1 passage
• Severe cerebral white matter lesions in ischemic stroke patients are associated with less time spent at home and early institutionalization.1 passage
• Severe edentulism is a major risk factor influencing stroke incidence in rural Ecuador (The Atahualpa Project).1 passage
• Sex difference in types and distribution of risk factors in ischemic and hemorrhagic stroke.1 passage
• Sex differences in cerebral venous thrombosis: A systematic analysis of a shift over time.1 passage
• Sex differences in intracranial and extracranial atherosclerosis in patients with acute ischemic stroke.1 passage
• Sex differences in predictors for cognitive decline and dementia in people with stroke or transient ischemic attack in the PROGRESS trial.1 passage
• Sex differences in stroke metrics among Southeast Asian countries: Results from the Global Burden of Disease Study 2015.1 passage
• Shared decision making after severe stroke-How can we improve patient and family involvement in treatment decisions?1 passage
• Short and long sleep durations are both associated with increased risk of stroke: a meta-analysis of observational studies.1 passage
• Short- and long-term exposure to air pollution increases the risk of stroke.1 passage
• Should minor stroke patients be thrombolyzed? A focused review and future directions.1 passage
• Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?1 passage
• Simple telephone call a feasible, useful and acceptable method of following up patients with cerebrovascular accidents: Prospective Cohort study in South India.1 passage
• Sirtuin/uncoupling protein gene variants and carotid plaque area and morphology.1 passage
• Sleep duration and risk of cardiovascular events: The SAVE study.1 passage
• Sleep for Stroke Management and Recovery Trial (Sleep SMART): Rationale and methods.1 passage
• Small cortical infarcts: prevalence, determinants, and cognitive correlates in the general population.1 passage
• Small intracerebral hemorrhages have a low spot sign prevalence and are less likely to expand.1 passage
• Small vessel occlusion is a high-risk etiology for early recurrent stroke after transient ischemic attack.1 passage
• Smartphone electrographic monitoring for atrial fibrillation in acute ischemic stroke and transient ischemic attack.1 passage
• Socioeconomic deprivation and mortality in people after ischemic stroke: The China National Stroke Registry.1 passage
• Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.1 passage
• Sparing of the hippocampus indicates better collateral blood flow in acute posterior cerebral artery occlusion.1 passage
• Spatial and temporal intracerebral hemorrhage patterns in Dutch-type hereditary cerebral amyloid angiopathy.1 passage
• Special topic section: linkages among cerebrovascular, cardiovascular, and cognitive disorders: Preventing dementia by preventing stroke: The Berlin Manifesto.1 passage
• Specialized stroke rehabilitation services in seven countries: Preliminary results from nine rehabilitation centers.1 passage
• Standardized measurement of quality of upper limb movement after stroke: Consensus-based core recommendations from the Second Stroke Recovery and Rehabilitation Roundtable.1 passage
• Standardized measurement of sensorimotor recovery in stroke trials: Consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable.1 passage
• Statin therapy and the risk of intracerebral haemorrhage: a nationwide observational study.1 passage
• Statin use in spontaneous intracerebral hemorrhage: a systematic review and meta-analysis.1 passage
• Statin-based therapy for primary and secondary prevention of ischemic stroke: A meta-analysis and critical overview.1 passage
• Statins and subarachnoid hemorrhage in Medicare patients with unruptured cerebral aneurysms.1 passage
• Statins as secondary preventives in patients with intracerebral hemorrhage.1 passage
• Statistical Analysis Plan for EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND) trial.1 passage
• Statistical analysis plan (SAP) for A Very Early Rehabilitation Trial (AVERT): an international trial to determine the efficacy and safety of commencing out of bed standing and walking training (very early mobilization) within 24 h of stroke onset vs. usual stroke unit care.1 passage
• Statistical analysis plan (SAP) for the Very Early Rehabilitation in Speech (VERSE) after stroke trial: an international 3-arm clinical trial to determine the effectiveness of early, intensive, prescribed, direct aphasia therapy.1 passage
• Statistical analysis plan for evaluating different intensities of blood pressure control in the ENhanced Control of Hypertension And Thrombolysis strokE stuDy.1 passage
• Statistical analysis plan for evaluating low- vs. standard-dose alteplase in the ENhanced Control of Hypertension and Thrombolysis strokE stuDy (ENCHANTED).1 passage
• Statistical analysis plan for pooled individual patient data from two landmark randomized trials (INTERACT2 and ATACH-II) of intensive blood pressure lowering treatment in acute intracerebral hemorrhage.1 passage
• Statistical analysis plan for the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trial.1 passage
• Statistical analysis plan for the Head Position in Stroke Trial (HeadPoST): An international cluster cross-over randomized trial.1 passage
• Statistical analysis plan for the Sleep Apnea cardioVascular Endpoints study: An international randomised controlled trial to determine whether continuous positive airways pressure treatment for obstructive sleep apnea in patients with CV disease prevents secondary cardiovascular events.1 passage
• Statistical analysis plan for the family-led rehabilitation after stroke in India (ATTEND) trial: A multicenter randomized controlled trial of a new model of stroke rehabilitation compared to usual care.1 passage
• Statistical analysis plan of the head position in acute ischemic stroke trial pilot (HEADPOST pilot).1 passage
• Stent-retriever alone vs. aspiration and stent-retriever combination in large vessel occlusion stroke: A matched analysis.1 passage
• Striped occipital cortex and intragyral hemorrhage: Novel magnetic resonance imaging markers for cerebral amyloid angiopathy.1 passage
• Stroke Epidemiology in an Australian Rural Cohort (SEARCH).1 passage
• Stroke admission outside daytime working hours delays mechanical thrombectomy and worsens short-term outcome.1 passage
• Stroke burden in Guinea: Results from the Conakry Ignace Deen Hospital stroke registry.1 passage
• Stroke care in Africa: A systematic review of the literature.1 passage
• Stroke care quality in China: Substantial improvement, and a huge challenge and opportunity.1 passage
• Stroke case fatality in sub-Saharan Africa: Systematic review and meta-analysis.1 passage
• Stroke doctors: Who are we? A World Stroke Organization survey.1 passage
• Stroke epidemiology and stroke policies in China from 1980 to 2017: A systematic review and meta-analysis.1 passage
• Stroke hospital admission rates in Brisbane and Queensland in 2015: Data from 11,072 cases.1 passage
• Stroke in Bahrain: rising incidence, multiple risk factors, and suboptimal care.1 passage
• Stroke in COVID-19: A systematic review and meta-analysis.1 passage
• Stroke in India: A systematic review of the incidence, prevalence, and case fatality.1 passage
• Stroke in the Middle-East and North Africa: A 2-year prospective observational study of intravenous thrombolysis treatment in the region. Results from the SITS-MENA Registry.1 passage
• Stroke in the Middle-East and North Africa: A 2-year prospective observational study of stroke characteristics in the region-Results from the Safe Implementation of Treatments in Stroke (SITS)-Middle-East and North African (MENA).1 passage
• Stroke in young cannabis users (18-49 years): National trends in hospitalizations and outcomes.1 passage
• Stroke incidence and case-fatality among Indigenous and non-Indigenous populations in the Northern Territory of Australia, 1999-2011.1 passage
• Stroke incidence, prevalence and mortality in women worldwide.1 passage
• Stroke network performance during the first COVID-19 pandemic stage: A meta-analysis based on stroke network models.1 passage
• Stroke preparedness in children: translating knowledge into behavioral intent: a systematic review and meta-analysis.1 passage
• Stroke prevention and control system in China: CSPPC-Stroke Program.1 passage
• Stroke progression and clinical outcome in ischemic stroke patients with a history of migraine.1 passage
• Stroke recurrence among South Asians with diabetes in Ontario, Canada.1 passage
• Stroke risk following traumatic brain injury: Systematic review and meta-analysis.1 passage
• Stroke severity and incidence of acute large vessel occlusions in patients with hyper-acute cerebral ischemia: results from a prospective cohort study based on CT-angiography (CTA).1 passage
• Stroke survivor and carer involvement in, and engagement with, studies adopted onto the NIHR Stroke Research Network portfolio: questionnaire survey.1 passage
• Stroke survivor follow-up in a national registry: Lessons learnt from respondents who completed telephone interviews.1 passage
• Stroke units in the Philippines: An observational study.1 passage
• Stroke while driving: Frequency and association with automobile accidents.1 passage
• Structural integrity of white matter tracts as a predictor of acute ischemic stroke outcome.1 passage
• Sudden unexpected death caused by stroke: A nationwide study among children and young adults in Denmark.1 passage
• Suggested modification of presentation of stroke trial results.1 passage
• Sustained impact of UK FAST-test public education on response to stroke: a population-based time-series study.1 passage
• Swipe out Stroke: Feasibility and efficacy of using a smart-phone based mobile application to improve compliance with weight loss in obese minority stroke patients and their carers.1 passage
• Symptomatic intracranial hemorrhage in the ALIAS Multicenter Trial: relationship to endovascular thrombolytic therapy.1 passage
• System-integrated technology-enabled model of care (SINEMA) to improve the health of stroke patients in rural China: Statistical analysis plan for a cluster-randomized controlled trial.1 passage
• Systematic evaluation of stroke thrombectomy in clinical practice: The German Stroke Registry Endovascular Treatment.1 passage
• Systematic review of organizational models for intra-arterial treatment of acute ischemic stroke.1 passage
• TALOS: a multicenter, randomized, double-blind, placebo-controlled trial to test the effects of citalopram in patients with acute stroke.1 passage
• TIA triage in emergency department using acute MRI (TIA-TEAM): a feasibility and safety study.1 passage
• TOOTH (The Open study Of dental pulp stem cell Therapy in Humans): Study protocol for evaluating safety and feasibility of autologous human adult dental pulp stem cell therapy in patients with chronic disability after stroke.1 passage
• TRIAGE-STROKE: Treatment strategy In Acute larGE vessel occlusion: Prioritize IV or endovascular treatment-A randomized trial.1 passage
• Tachycardia burden in stroke unit is associated with functional outcome after ischemic stroke.1 passage
• Taking Charge after Stroke: A randomized controlled trial of a person-centered, self-directed rehabilitation intervention.1 passage
• Targeting aspirin in acute disabling ischemic stroke: an individual patient data meta-analysis of three large randomized trials.1 passage
• Targets for improving dispatcher identification of acute stroke.1 passage
• Telehealth coaching to improve self-management for secondary prevention after stroke: A randomized controlled trial of Stroke Coach.1 passage
• Telemedical strategies for the improvement of secondary prevention in patients with cerebrovascular events-A systematic review and meta-analysis.1 passage
• Temporal evolution and spatial distribution of quantitative T2 MRI following acute ischemia reperfusion injury.1 passage
• Temporal trends in stroke incidence and case-fatality rates in Arcadia, Greece: A sequential, prospective, population-based study.1 passage
• Temporary application of lower body positive pressure improves intracranial velocities in symptomatic acute carotid occlusion or tight stenosis: A pilot study.1 passage
• Ten-year risk of stroke in patients with previous cerebral infarction and the impact of carotid surgery in the Asymptomatic Carotid Surgery Trial.1 passage
• Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials.1 passage
• Tenecteplase in wake-up ischemic stroke trial: Protocol for a randomized-controlled trial.1 passage
• Tenecteplase versus alteplase after acute ischemic stroke at high age.1 passage
• Tenecteplase versus alteplase before endovascular thrombectomy (EXTEND-IA TNK): A multicenter, randomized, controlled study.1 passage
• Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials.1 passage
• The ATTEND trial: An alternative explanation with implications for future recovery and rehabilitation clinical trials.1 passage
• The Acute S1 passage
• The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods.1 passage
• The Chemical Optimization of Cerebral Embolectomy trial: Study protocol.1 passage
• The China Stroke Secondary Prevention Trial (CSSPT) protocol: a double-blinded, randomized, controlled trial of combined folic acid and B vitamins for secondary prevention of stroke.1 passage
• The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods.1 passage
• The Dutch String-of-Pearls Stroke Study: protocol of a large prospective multicenter genetic cohort study.1 passage
• The European Stroke Organisation Guidelines: a standard operating procedure.1 passage
• The Indian Stroke Scale: Development and validation of a scale to measure participation in daily activities among patients with stroke in India.1 passage
• The Insulin Resistance Intervention after Stroke trial: A perspective on future practice and research.1 passage
• The International comparison of Systems of care and patient outcomes In minor Stroke and Tia (InSIST) study: A community-based cohort study.1 passage
• The Know Your Numbers (KYN) program 2008 to 2010: impact on knowledge and health promotion behavior among participants.1 passage
• The Mild and Rapidly Improving Stroke Study (MaRISS): Rationale and design.1 passage
• The PRE-hospital Stroke Treatment Organization.1 passage
• The START nomogram for individualized prediction of the probability of unfavorable outcome after intravenous thrombolysis for stroke.1 passage
• The Stroke Riskometer(TM) App: validation of a data collection tool and stroke risk predictor.1 passage
• The aspirin in reducing events in the elderly trial: Statistical analysis plan.1 passage
• The association between aortic regurgitation and undetermined embolic infarction with aortic complex plaque.1 passage
• The association between computed tomography angiography timing and workflow times in patients with acute ischemic stroke.1 passage
• The association between lesion location and functional outcome after ischemic stroke.1 passage
• The association of ankle-brachial index with silent cerebral small vessel disease: results of the Atahualpa Project.1 passage
• The benefit of EXtending oral antiCOAgulation treatment (EXCOA) after acute cerebral vein thrombosis (CVT): EXCOA-CVT cluster randomized trial protocol.1 passage
• The brain health index: Towards a combined measure of neurovascular and neurodegenerative structural brain injury.1 passage
• The burden of stroke in México.1 passage
• The concept of sporadic cerebral small vessel disease: A road map on key definitions and current concepts.1 passage
• The coronal plane maximum diameter of deep intracerebral hemorrhage predicts functional outcome more accurately than hematoma volume.1 passage
• The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.1 passage
• The effect of cerebellar transcranial direct current stimulation to improve standing balance performance early post-stroke, study protocol of a randomized controlled trial.1 passage
• The effect of rapamycin treatment on cerebral ischemia: A systematic review and meta-analysis of animal model studies.1 passage
• The efficacy and safety of cilostazol in ischemic stroke patients with peripheral arterial disease (SPAD): protocol of a randomized, double-blind, placebo-controlled multicenter trial.1 passage
• The efficacy of Wii-based Movement Therapy for upper limb rehabilitation in the chronic poststroke period: a randomized controlled trial.1 passage
• The emerging value of serum D-dimer measurement in the work-up and management of ischemic stroke.1 passage
• The forecast for future clinical trials and clinical trialists-Storms or sunshine?1 passage
• The future of endovascular treatment: Insights from the ESCAPE investigators.1 passage
• The growth rate of early DWI lesions is highly variable and associated with penumbral salvage and clinical outcomes following endovascular reperfusion.1 passage
• The iScore predicts total healthcare costs early after hospitalization for an acute ischemic stroke.1 passage
• The impact of COVID-19 on stroke, sex differences in outcome after thrombolysis, and general versus local anesthesia for thrombectomy for posterior circulation stroke.1 passage
• The impact of atrial fibrillation and long-term oral anticoagulant use on all-cause and cardiovascular mortality: A 12-year evaluation of the prospective Brazilian Study of Stroke Mortality and Morbidity.1 passage
• The impact of risk factor trends on intracerebral hemorrhage incidence over the last two decades-The Tromsø Study.1 passage
• The incidence of pregnancy-related stroke: A systematic review and meta-analysis.1 passage
• The ischemic penumbra: From concept to reality.1 passage
• The multiarm optimization of stroke thrombolysis phase 3 acute stroke randomized clinical trial: Rationale and methods.1 passage
• The network of Shanghai Stroke Service System (4S): A public health-care web-based database using automatic extraction of electronic medical records.1 passage
• The obesity paradox in stroke: lower mortality and lower risk of readmission for recurrent stroke in obese stroke patients.1 passage
• The potential health and economic impact of improving stroke care standards for Australia.1 passage
• The potential power of robotics for upper extremity stroke rehabilitation.1 passage
• The predictors and clinical impact of intraventricular hemorrhage in patients with aneurysmal subarachnoid hemorrhage.1 passage
• The prevalence of fatigue after stroke: A systematic review and meta-analysis.1 passage
• The progressive course of neurological symptoms in anterior choroidal artery infarcts.1 passage
• The randomized study of endovascular therapy with versus without intravenous tissue plasminogen activator in acute stroke with ICA and M1 occlusion (SKIP study).1 passage
• The relation between total cerebral small vessel disease burden and gait impairment in patients with minor stroke.1 passage
• The risk of stroke in spouses of people living with dementia in Korea.1 passage
• The role of adipokines in ischemic stroke risk stratification.1 passage
• The shape of middle cerebral artery and plaque location: high-resolution MRI finding.1 passage
• The state of stroke services across the globe: Report of World Stroke Organization-World Health Organization surveys.1 passage
• The stroke 'Act FAST' campaign: remembered but not understood?1 passage
• The use of hypnotherapy as treatment for functional stroke: A case series from a single center in the UK.1 passage
• Therapeutic hypothermia for intracerebral hemorrhage: Systematic review and meta-analysis of the experimental and clinical literature.1 passage
• Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.1 passage
• Threshold for NIH stroke scale in predicting vessel occlusion and functional outcome after stroke thrombolysis.1 passage
• Thrombectomy accessibility after transfer from a primary stroke center: Analysis of a three-year prospective registry.1 passage
• Thrombectomy in patients ineligible for iv tPA (THRILL).1 passage
• Thromboelastography in patients with acute ischemic stroke.1 passage
• Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion.1 passage
• Thrombolysis in acute ischemic stroke is associated with lower long-term hospital bed day use: A nationwide propensity score-matched follow-up study.1 passage
• Thrombolysis in elderly stroke patients in Italy (TESPI) trial and updated meta-analysis of randomized controlled trials.1 passage
• Thrombolysis outcomes according to arterial characteristics of acute ischemic stroke by alteplase dose and blood pressure target.1 passage
• Thrombolysis related symptomatic intracranial hemorrhage in estimated versus measured body weight.1 passage
• Thrombolysis: Improving door-to-needle times for ischemic stroke treatment - A narrative review.1 passage
• Time dependence of reliability of noncontrast computed tomography in comparison to computed tomography angiography source image in acute ischemic stroke.1 passage
• Time patterns in multiple acute cerebral infarcts.1 passage
• Time-dependent shift of the relationship between systolic blood pressure and clinical outcome in acute lacunar stroke.1 passage
• Time-dependent, dynamic prediction of fatty acid-binding protein 4, Galectin-3, and soluble ST2 measurement with poor outcome after acute stroke.1 passage
• Top 10 global educational topics in stroke: A survey by the World Stroke Organization.1 passage
• Total small vessel disease score and cerebro-cardiovascular events in healthy adults: The Kashima scan study.1 passage
• Tranexamic acid for acute intracerebral hemorrhage growth predicted by spot sign trial: Rationale and design.1 passage
• Transcranial Doppler screening for stroke risk in children with sickle cell disease: a systematic review.1 passage
• Transcranial direct current stimulation (tDCS): does it have merit in stroke rehabilitation? A systematic review.1 passage
• Transfer to the Local Stroke Center versus Direct Transfer to Endovascular Center of Acute Stroke Patients with Suspected Large Vessel Occlusion in the Catalan Territory (RACECAT): Study protocol of a cluster randomized within a cohort trial.1 passage
• Transient ischemic attack: Incidence and early risk of stroke in northern Portugal from 1998-2000 to 2009-2011.1 passage
• Translational perspectives on perfusion-diffusion mismatch in ischemic stroke.1 passage
• Treatment evaluation of acute stroke for using in regenerative cell elements (TREASURE) trial: Rationale and design.1 passage
• Treatment in patients who are not eligible for intravenous alteplase: MR CLEAN subgroup analysis.1 passage
• Treatment of intracerebral hemorrhage: From specific interventions to bundles of care.1 passage
• Treatment of post-stroke aphasia: A narrative review for stroke neurologists.1 passage
• Treatment with exenatide in acute ischemic stroke trial protocol: A prospective, randomized, open label, blinded end-point study of exenatide vs. standard care in post stroke hyperglycemia.1 passage
• Trends in hospitalizations and cost associated with stroke by age, United States 2003-2012.1 passage
• Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.1 passage
• Trends in recruitment of women and reporting of sex differences in large-scale published randomized controlled trials in stroke.1 passage
• Trends in risk of recurrence after the first ischemic stroke in adults younger than 55 years of age in Sweden.1 passage
• Trends of risk profile among middle-aged adults hospitalized for acute ischemic stroke in United States 2006-2017.1 passage
• Triglyceride-glucose index is associated with early neurological deterioration in single subcortical infarction: Early prognosis in single subcortical infarctions.1 passage
• Trimming the fat in acute ischemic stroke: an assessment of 24-h CT scans in tPA patients.1 passage
• Two decades of nation-wide community-based stroke support - The Singapore National Stroke Association.1 passage
• Type of admission is associated with outcome of spontaneous subarachnoid hemorrhage.1 passage
• Unclear-onset intracerebral hemorrhage: Clinical characteristics, hematoma features, and outcomes.1 passage
• Unclear-onset stroke: Daytime-unwitnessed stroke vs. wake-up stroke.1 passage
• Unemployment, government healthcare spending, and cerebrovascular mortality, worldwide 1981-2009: an ecological study.1 passage
• Uric acid therapy improves the outcomes of stroke patients treated with intravenous tissue plasminogen activator and mechanical thrombectomy.1 passage
• Use of computed tomography perfusion for acute stroke in routine clinical practice: Complex scenarios, mimics, and artifacts.1 passage
• Use of risk scores for predicting new atrial fibrillation after ischemic stroke or transient ischemic attack-A systematic review.1 passage
• Utility-weighted modified Rankin Scale: Still too crude to be a truly patient-centric primary outcome measure?1 passage
• Utstein recommendation for emergency stroke care.1 passage
• Validation and iteration of CT perfusion defined malignant profile thresholds for acute ischemic stroke.1 passage
• Validation of a TIA recognition tool in primary and secondary care: implications for generalizability.1 passage
• Validation of an automated ASPECTS method on non-contrast computed tomography scans of acute ischemic stroke patients.1 passage
• Validation of the simplified modified Rankin scale for stroke trials: Experience from the ENCHANTED alteplase-dose arm.1 passage
• Value of utilizing both ASPECTS and CT angiography collateral score for outcome prediction in acute ischemic stroke.1 passage
• Variation of stroke-associated pneumonia in stroke units across England and Wales: A registry-based cohort study.1 passage
• Vascular tortuosity may be related to intracranial artery atherosclerosis.1 passage
• Very short paroxysms account for more than half of the cases of atrial fibrillation detected after stroke and TIA: a systematic review and meta-analysis.1 passage
• Viral and parasitic pathogen burden and the association with stroke in a population-based cohort.1 passage
• Visual aid tool to improve decision making in acute stroke care.1 passage
• Vitamin D deficiency and incident stroke risk in community-living black and white adults.1 passage
• Vorapaxar monotherapy for secondary stroke prevention: A call for randomized trial.1 passage
• Weakly supervised multitask learning models to identify symptom onset time of unclear-onset intracerebral hemorrhage.1 passage
• Weekend hospital discharge is associated with suboptimal care and outcomes: An observational Australian Stroke Clinical Registry study.1 passage
• What are the next breakthroughs in the management of acute intracerebral hemorrhage?1 passage
• What is the median volume of intracerebral hemorrhage and is it changing?1 passage
• What is the relationship among penumbra volume, collaterals, and time since onset in the first 6 h after acute ischemic stroke?1 passage
• What is the value of conducting a trial of r-tPA for the treatment of mild stroke patients?1 passage
• What's new in stroke? Phase III randomized clinical trials of 2012-2014.1 passage
• Where to now? AVERT answered an important question, but raised many more.1 passage
• Which stroke patients gain most from intermittent pneumatic compression: further analyses of the CLOTS 3 trial.1 passage
• White matter disease and an incomplete circle of Willis.1 passage
• White matter hyperintensities of presumed vascular origin: a population-based study in rural Ecuador (The Atahualpa Project).1 passage
• White matter hyperintensity volume predicts persistent cognitive impairment in transient ischemic attack and minor stroke.1 passage
• Who will benefit more from low-dose alteplase in acute ischemic stroke?1 passage
• Why do transient ischemic attack patients have higher early stroke recurrence risk than those with ischemic stroke? Influence of patient behavior and other risk factors in the North Dublin Population Stroke Study.1 passage
• Why hospital design matters: A narrative review of built environments research relevant to stroke care.1 passage
• Worse prognosis in women, compared with men, after thrombolysis: An individual patient data pooling study of Asian acute stroke registries.1 passage
• Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation.1 passage
• Yield of CT perfusion for the evaluation of transient ischaemic attack.1 passage
• close: Closure of patent foramen ovale, oral anticoagulants or antiplatelet therapy to prevent stroke recurrence: Study design.1 passage
• e-ASPECTS derived acute ischemic volumes on non-contrast-enhanced computed tomography images.1 passage
• e-ASPECTS software is non-inferior to neuroradiologists in applying the ASPECT score to computed tomography scans of acute ischemic stroke patients.1 passage
• qTICI: Quantitative assessment of brain tissue reperfusion on digital subtraction angiograms of acute ischemic stroke patients.1 passage